Stephen G. Reich
Page 1 of 39
CURRICULUM VITAE
Stephen G. Reich, M.D., F.A.A.N.
February 23, 2015
Personal Information
Professional Address:
Department of Neurology
University of Maryland School of Medicine
110 S. Paca, 3rd Floor
Baltimore, MD 21201
Phone: 410-328-2164
Fax: 410-328-0167
Email: sreich@som.umaryland.edu
Education
University of Kansas
1975-1976
Tulane University
1976-1979
B.S. Mathematics
B.A. Latin American Studies
(with honors)
Tulane University
School of Medicine
1979-1983
M.D.
Mt. Sinai Hospital
1983-1984
Internship in Internal Medicine
Cleveland, Ohio
Case Western Reserve/
University Hospitals of
Cleveland, Ohio
1984-1987
Resident in Neurology
(Dr. Robert Daroff)
July 1987June 1988
Fellow - Movement Disorders
(Dr. Mahlon DeLong)
Post-Graduate Training
The Johns Hopkins Hospital
Certifications
American Board of Psychiatry and Neurology, 1989
Medical Licensures
Ohio, 1983-1987
Maryland 1987-, #D37272
Employment History
Instructor, Neurology,
The Johns Hopkins University
School of Medicine
July 1988-June 1990
Stephen G. Reich
Page 2 of 39
Assistant Professor,
Neurology, The Johns
Hopkins University School
of Medicine
1990-1997
Associate Professor,
Neurology, The Johns
Hopkins University School
of Medicine
1997-June 30, 2002
Co-Director, Johns Hopkins
Parkinson’s Disease Center
1991-1994
Director, Johns Hopkins
Parkinson's Disease Center
1994-June 30, 2002
Associate Professor, Neurology
The University of Maryland
School of Medicine
July 1, 2002-June 30, 2004
Co-Director, Maryland
Parkinson’s Disease and
Movement Disorders Center
July 1, 2002-
Professor, Neurology
The University of Maryland
School of Medicine
July 1, 2004-
Professor with tenure, Neurology July 1, 2006The University of Maryland
School of Medicine
The Frederick Henry Prince
Distinguished Professor
in Neurology
September 22, 2011-
Professional Memberships
American Academy of Neurology 1986- (Fellow 2004)
Movement Disorders Society, 2004American Neurological Association 2000American Association for the History of Medicine 1999Parkinson Study Group 1989Dystonia Study Group
Awards and Honors
1978
1979
1978-79
1983
Pi Mu Epsilon, National Mathematics Honorary Society, Tulane University
Phi Alpha Theta, National History Honorary Society, Tulane University
President, The Tulane History of Medicine Society
Isaac Ivan Lemann Award in the History of Medicine, Tulane Medical School, May
14
Stephen G. Reich
Page 3 of 39
1983
1983
1992
1992
1993
1993
1994
1995
1996
1996
1997
1998
1999
1999
2002
2003
2003-04
2004
2004-05
2005
2005-06
2005-06
2006
2007-8
2009
2009
2011
2012
2013
Mark Gibbs III Memorial Award, "for outstanding interest in University matters,"
Tulane Medical School, June 4
Student Speaker, Tulane Medical School graduation, June 4
Certificate Of Excellence in Teaching, presented by medical students, The Johns
Hopkins University School of Medicine
Baltimore Best Doctors, Baltimore Magazine, March
Hooded Students at graduation ceremony, elected by class of 1993, The Johns
Hopkins University School of Medicine
George J. Stuart Award "to an outstanding clinical teacher," presented by senior
class, 1993,The Johns Hopkins University School of Medicine
Marshall at graduation ceremony, The Johns Hopkins University School
of Medicine, chosen by senior class
Baltimore Best Doctors, Baltimore Magazine, June
Certificate of Excellence in Teaching, presented by medical students, The Johns
Hopkins University School of Medicine, class of 1996
Grand Marshall at graduation ceremony, The Johns Hopkins University
School of Medicine
Professor’s Award for Excellence in Teaching, The Johns Hopkins University
School of Medicine
Certificate of Appreciation from the Baltimore/Johns Hopkins Dystonia Support
Group, 1998
American Neurological Association
American Parkinson's Disease Association Certificate of Appreciation,
Anne Arundel Maryland County Chapter
Baltimore Best Doctors, Baltimore Magazine, November
The Edmund G. Beacham Lecture, “Is Parkinson’s Disease Really a
Waiting Room Diagnosis?” Current Topics in Geriatrics Course,
Sponsored by The Johns Hopkins University School of Medicine and The
American Geriatrics Society, Baltimore, MD, October 16
Teaching Commendation, Pathophysiology and Therapeutics,
University of Maryland School of Medicine, Class of 2006
Fellow, American Academy of Neurology
Teaching Commendation, Pathophysiology and Therapeutics, University of
Maryland School of Medicine, Class of 2007
Golden Hammer, Teaching award by Neurology residents
Teaching Commendation, Pathophysiology and Therapeutics, University of
Maryland School of Medicine, Class of 2008
Teaching Commendation, Pathophysiology and Therapeutics, University of
Maryland School of Medicine, Class of 2009
The “Buddy Award for Enduring Spirit” presented by the Parkinson’s Action
Network at annual Udall dinner
Teaching Commendation, Pathophysiology and Therapeutics, University of
Maryland School of Medicine, Class of 2010
Stephens Visiting Professor, University of Colorado Department of Neurology
Teaching commendation in Pathophysiology & Therapeutics course, University of
Maryland School of Medicine, Class of 2011
The Frederick Henry Prince Distinguished Professor in Neurology
Co-winner (with Daniel Gold, M.D.) of the 2012 Resident and Fellow Writing
Award from Neurology
Baltimore Best Doctors, Baltimore Magazine, Novemeber 2013.
Administrative Service
Institutional Service
Stephen G. Reich
Page 4 of 39
University of Maryland (2002- )
Co-director, Neurology Residency Program, 2002Residency Oversite Committee, 2002Clinical Practice Committee, 2002-2010
Inpatient Committee, 2003-2004
Director, Neurology Outpatient Clinic, 2004-2010
Coordinator, Neurology Grand Rounds, 2003Interviewer, Medical School Admissions Committee, 2004Clinical Education Committee, Co-Chair, 2009
Ad Hoc committee on scientific misconduct, 2012Appeals committee 2010Co-director Annual Town-Gown Neurology Update 2012
Director, Annual William J. Weiner Town-Gown Neurology Update 2013Johns Hopkins (1987-2002)
Neurology Quality Assurance Committee, Johns Hopkins, 1989 - 1991
Continuing Education Committee, Johns Hopkins, 1990 - 1997
Staff Conference Committee, Johns Hopkins, 1991 - 1992
Medical School Council, Johns Hopkins, 1992 - 1996
Medical School Admissions Committee, Johns Hopkins, 1993 - 1996
Educational Policy Committee, Johns Hopkins, 1996 - 1997
Committee on Revision of Promotion Guidelines, Johns Hopkins, 1997
Neurology Library Committee, Johns Hopkins, 1997 - 2000
Medical School Admission Committee (Application Screening), Johns Hopkins 1999
Director, Neurology Residency Selection, Johns Hopkins,1991 – 1998
Co-Director, Neurology for the Primary Practitioner Course, Sponsored by Department of
Neurology, The Johns Hopkins Hospital, 1992 – 2000. Director 2001.
Director, Neurology section of Topics in Internal Medicine, Johns Hopkins, 1993 – 2002.
Medical Student Advisor, Johns Hopkins, 1995 – 2000
Local and National Service
Ad Hoc reviewer for:
Neurology
Annals of Neurology
Journal of Clinical Nutrition
Dysphagia
American Journal of Medicine
The Lancet
The Neurologist (Editorial board 1997- )
Journal of the Neurological Sciences
Bulletin of the History of Medicine
Movement Disorders (Editorial board 2007-)
The Johns Hopkins University Press
Oxford University Press
The New England Journal of Medicine
Journal of Clinical Outcomes Management
Ophthalmic Plastic and Reconstructive Surgery
Journal of Neurology, Neurosurgery and Psychiatry
Clinical and Experimental Ophthalmology
CNS Spectrums
European Journal of Neurology
Stephen G. Reich
Page 5 of 39
Journal of Clinical Psychopharmacology
Consultant
Brain
Expert Opinion on Pharmacotherapy
Progress in Neuro-Psychopharmacology & Biological Psychiatry
Psychosomatics
Lancet Neurology
General Hospital Psychiatry
Neurosurgery
Neurology Clinical Practice
Neurotherapeutics
UpToDate
Tremor and other Hyperkinetic Movements
Bladder
Cleveland Clinic Journal of Medicine
Physical Therapy
Neurotherapeutics
Somatosensory & Motor Research
Editorial Board, Parkinsonism and Related Disorders, 2013Editorial Board/Associate Editor, Journal of Clinical Movement Disorders, 2014Editorial Board, The Neurologist, 1997 – 2007
Editorial Board, Movement Disorders, 2007-2010
Editorial Board, Practical Reviews in Neurology (Audiotape), 1998 – 2000
Board of Directors, The Society for Progressive Supranuclear Palsy, Chairman of the Board,
1992 – 1998; Chairman emeritus 1999Medical Advisory Board, The Society for Progressive Supranuclear Palsy, Europe, 1998-2003
Medical Advisor, Johns Hopkins Chapter of Dystonia Medical Research Foundation, 19972002
Professional Advisory Board, National Spasmodic Torticollis Association, 2000-2008
Neurology editor, Doody Book Review Service, 2004-2007
Grant reviewer:
MRC Clinical Training Scientist Award for Applied Clinical Research
Veteran's Administration Merit Review Grant
USAID
American Academy of Neurology
Presented highlights of movement disorders, 2004 annual meeting
Abstract reviewer, Movement Disorders, 2005 annual meeting
Practice parameter committee, Diagnosis of Parkinson’s disease
Executive committee, Section on Movement Disorders, 2005Co-chair, Plenary session: Movement Disorders- Genetics, Pathophysiology and
Epidemiology, Annual meeting, 2005
Stephen G. Reich
Page 6 of 39
Counselor, History section, 2012Member, Topic Working Group, 2014
American Neurological Association
History Committee, 2004-07
Parkinson Study Group
Nominating Committee, 2007
Dystonia Study Group
Rating scales committee
Movement Disorders Society
Faculty, 2006 Annual Meeting, Kyoto, Japan
Faculty, De Novo Parkinson’s Disease Course, San Francisco, CA, September 13,
Course director: “Differential Diagnosis of Parkinsonism,” Paris, 2009
Education Committee 2009Course director: “Differential Diagnosis of Parkinsonism,” Buenos Aires, 2010
Participant in Video Olympics, Buenos Aires, 2010
Pan American Section Education Committee 2013-
2008
Teaching Service
University of Maryland (2002- )
Medical Students
Freshman orientation, small group leader, 2002 (12 students)
Annual lectures:
Freshman Neurocience Course, Clinical Correlation: Basal Ganglia Disorders
Freshman Anatomy: The Cranial Nerves
Sophomore Pathophysiology & Therapeutics Course: “Motor Disorders” & small group leader:
“Motor Disorders”
Sophomore Physical Diagnosis: The Neurological Examination 2002-2010
Director, Neurology section of Sophomore Physical Diagnosis course, 2003Neurology Attending, 2 Months/year; 3-5 students per rotation
Advisor, Student Interest Group in Neurology
Group leader, Transition to 3rd year orientation, 2005
Neurology Residents
Monthly Movement Disorders video conference
Various lectures
Clinic supervision
Neurology Attending (2 months per year)
Director, Annual Movement Disorders Course
November 16, 2002
November 1, 2003
November 12, 2004
December 16, 2005
Stephen G. Reich
Page 7 of 39
Johns Hopkins (1987-2002)
Annual Clinical Correlation Lecuture: Motor Disorders, Freshman Class. 1989- 2001
Annual Lectures to Sophomore Class: The Neurological Examination 1989- 2001; Localization
in Clinical Neurology (1995-2002); Movement Disorders (1989-2002)
Neuropathology Group Instructor, 1989-2000
Physician and Society course group instructor, 1995-2002
Clinical Skills group instructor, 1989-1991
Director, Neurology section of Clinical Skills, 1993-1998
Weekly outpatient rotation for Jr. and Sr. medical students, 1989-2002
Weekly bedside teaching rounds for Neurology clerkship, 2001-2002
Neurology clerkship lectures (6-10 per year): Headache; Movement disorders, 1994-2002
Neurology Ward or Consult Attending ; 1 month per year, 1988-2002
Neurology Resident lectures, 2-5 per year, 1988-2002
Movement Disorders Outpatient rotation for residents in Neurology, Psychiatry, Internal
Medicine, Physical Medicine 1988-2002
Neurology outpatient rotation for Johns Hopkins Undergraduates, 1989-1997
Master Clinician Course for Johns Hopkins Undergraduates, 2 week course, 1999-2002
American Academy of Neurology Annual Meeting
2001
Course instructor: “The Final Answer”
2003
Course director: “Parkinson-Plus Syndromes”
Course faculty: Movement Disorders: “10 Pitfalls in the diagnosis of Parkinson’s disease”
2004
Course director: “Parkinson-Plus Syndromes”
Facult, Crossfire course: “Movement disorders”
Faculty, Movement Disorders course: “Eye movements in parkinsonism”
2005
Course director: “Parkinson-Plus Syndromes”
2006
Course director: “The 10 Most Common Pitfalls in the Diagnosis of Parkinson’s Disease”
2007
Course director: “The 10 Most Common Pitfalls in the Diagnosis of Parkinson’s Disease”
Course director: “Clinical Pearls in Bedside Neurology.”
2008
Course director: “The 10 Most Common Pitfalls in the Diagnosis of Parkinson’s Disease”
Course director: “Clinical Pearls in Bedside Neurology.”
2009
Course director: “The 10 Most Common Pitfalls in the Diagnosis of Parkinson’s Disease”
Course director: “Clinical Pearls in Bedside Neurology.”
Stephen G. Reich
Page 8 of 39
2010
Course director: “Bell’s Palsy”
Faculty: “The Dystonias: Diagnosis, Treatment and Update on Causes
Faculty: “Movement Disorders,” Neurology Update II
2011
Faculty, Fall Conference: “Update on Movement Disorders”
2012
Faculty: Neurology update course
Faculty: Dystonia course
Faculty: Unusual movement disorders course
2013
Director: Movement Disorders Therapeutics: A Case Based Approach
Faculty: Dystonia course
2014
Faculty: History of Neurology Course: “History of Parkinson’s disease”
Faculty: Neurology Update: “Movement Disorders”
Director: Movement Disorders Therapeutics: A Case Based Approach
Grant Support
Site PI (2012) A Phase II, Multi-Centre, Randomized, Double-Blind, Placebo-Controlled,
Parallel Group Study to Investigate the Efficacy, Safety, and Tolerability of Cogane
(PYM50028), a Novel, Orally Active Neurotrophic Factor Inducer, in Male and Female
Subjects with Early-Stage Parkinson’s Disease When Administered Once Daily for 28
Weeks. Sponsor: Phytopharm plc.
Site PI (2012) A double-blind, randomized, placebo controlled study of the safety and
efficacy of SYN115 as adjunctive therapy in Levodopa-treated PD subjects with end of dose
wearing off. Biotie
Site PI U54 NS065701 (PI: Jinnah, CoPI: Perlmutter)
9/30/09 –
NIH-NINDS/ORDR-NCATS
The Dystonia Coalition
The goal of this project is to establish a multicenter network for clinical and translational
studies focusing on primary dystonias.
Site Principal Investigator [2008- ] A Pilot Trial of Lithium in Subjects with Progressive
Supranuclear Palsy or Corticobasal Degeneration – Phase II. A Multicenter Trial of the
NINDS Pilot Therapeutics Network (NPTUNE); Supported by: The National Institute of
Neurological Disorders and Stroke (NINDS).
Site Principal Investigator [2008- ] Effects of Coenzyme Q10 in Parkinsons disease –
Phase III (QE3). Supported by: the National Institute of Neurological Disorders and Stroke
(NINDS).
Stephen G. Reich
Page 9 of 39
Site Principal Investigator [2008- ] Chiltern. A Multi-Center, Double-Blind, Randomized,
Placebo-Controlled, Parallel-Group Withdrawal-Design Study to Assess the Clincal Effect of
Droxidopa in Subjects with Primary Autonomic Failrure, Dopamine Beta Hydroxylase
Deficiency or Non-Diabetic Neuropathy and Symptomatic Neurogenic Orthotension [Total
award TBA].
Site Principal Investigator [2006-] Genetic and Environmental Risk Factors for PSP.
1RO1AG024040-01A2 NIH/NINDS (Dr. Irene Litvan, PI)
Principal Investigator [2006-2007]: GE Healthcare. An Open Label, Phase II Study to Assess
the Safety and Efficacy of Technetium (99mTc) NC100697 Injection in Detecting or Excluding
Dopaminergic Deficits in Subjects with 1 or More Signs of a Parkinsonian Syndrome [Total
award: $58,375]
Co-investigator [2004-2006]: Kyowa Pharmaceuticals. A Long-Term, Multicenter, Open-Label
Safety Study with Oral 20 OR 40 MG/D Doses OF KW-6002 (Istradefylline) as Treatment for
Parkinson’s Disease in Patients with Motor Response Complications on Levodopa Therapy
[Total award: $80,000]
Principal Investigator [2004-2005]: Guilford Pharmaceticals. A Phase II Single-Center, Open
Label Pilot Study to Evaluate the Effects of GPI 1485 1000mg qid on Objective Measures of
Motor Activity and Olfactory Function in Patients with Parkinson’s Disease [Total award:
$84,944]
Principal Investigator [2004-]: Pathogenesis and Diagnosis of Multiple System Atrophy. 1PO1
NSO44233-01A1 NIH/NINDS (Cliff Shults, PI). [$28,000]. This is a multi-center program project
to study pathogenic factors for MSA and to evaluate and refine clinical and laboratory
assessments used to diagnose and follow the course of the illness.
Principal Investigator [2004-2006]:Validation of the ANAM Test Battery in Parkinson’s
Disease, Department of Defense [Total Award: $409,869 (20% effort)]. The objective of this
pilot study is to demonstrate the feasibility and clinical utility of selected tests from the
Automated Neuropsychological Assessment Metrics (ANAM) test system for assessing
cognitive, mood, and motor symptoms in Parkinson’s disease.
Co-Investigator [2002-]: A Phase II, Multi-Center, Randomized, Double-Blind, PlaceboControlled, Parallel-Group, 2 Year Study to Evaluate the Effects of GPI 1485 (1000 mg QID)
on (123 I) B-CIT/ SPECT Scanning and Clinical Efficacy in Symptomatic Parkinson's
Disease Patients Receiving Dopamine Agonist Therapy [Total award: $168,960; Indirects:
$33,792]
Principal Investigator [2002-2005]: Cephalon & Parkinson Study Group. A Randomized,
Double-Blind, Placebo-Controlled, Dose Finding Study to Assess the Efficacy and Safety of
CEP-1347 in Patients with Early Parkinson's Disease (PRECEPT) [Total award: $233,355;
Indirects: $46,665]
Principal Investigator [2000- 2001]: Multi-center, double-blind, placebo controlled study of the
tolerability and effect of entacapone in Parkinson's subjects with end-of-dose wearing off
symtoms occurring no earlier than four hours after their most recent carbidopa/levodopa dose.
Novartis Pharmaceuticals [Total award: $36,832.41; Indirects: $7,734.80]
Principal Investigator [2000- 2001]: Randomized, double-blind, placebo controlled, parallel
group, six month safety, efficacy, and neuroimaging trial of AMG-474-00 in the treatment of
patients with Parkinson's disease. AMGEN Pharmaceuticals [Total award: $48,300.00;
Indirects: $10,143.00]
Stephen G. Reich
Page 10 of 39
Principal Investigator [2000-2002]: Multi-center, randomized, double-blind, double dummy,
parallel group study comparing TV-1203/carbidopa/levodopa tablets with carbidopa/levodopa
tablets in advanced Parkinson's disease patients with motor fluctuations. TEVA
Pharmaceuticals/Parkinson Study Group [Total award: $29,014.25; Indirects: $ 7,253.56]
Principal Investigator [2000- 2001]: "Treatment of Dementia in Parkinson's Disease with
Aricept" Esai Pharmaceuticals (Ira Leroi, M.D. Principle Investigator) [5% effort].
Principal Investigator [5/01-5/04]: "Neurobiology of Dystonia" sponsored by NINDS (Hyder
Jinnah, M.D., Principle Investigator; $1,106,792 total award; indirect $406,792.00) [10% effort,
ending 6/30/02].
Principal Investigator [1999-]: "The Organized Genetics Initiative (PROGENI)," Multicenter
investigation of suseptibility genes in Parkinson's disease, NINDS, (Cliff Shults, Principle
Investigator) [Total award: $6,825.00; Indirects: $1,706.25].
Principal Investigator [1999-2001]: "Effects of Co-enzyme Q10 in early Parkinson's disease,"
Multicenter trial sponsored by NINDS Program Pilot Clinical Trial Grant for Neurological
Disease. [Total: $50,079.57; Indirects: $12,677.43]
Principal Investigator [1997- 1999]: An open label, dose escalation, safety and tolerability
study of botulinum toxin type B (BotB) in patients with cervical dystonia. Athena
Neurosciences [Total award: $82,057.00; Indirects: $17,231.97].
Principal Investigator [1996]: "Phase II study of the sensitivity and specificity of Dopascan
injection administered to healthy controls and subjects with Parkinson's disease,
progressive supranuclear palsy, and essential tremor." Guilford Pharmaceuticals and
Parkinson Study Group. [Total award: $85,117.50; Indirects: $17,874.75]
Co-Investigator [1996-1999]: "Dopamine transporter imaging by PET in aging and disease"
National Institute of Aging, James J. Frost, Principle Investigator. [Total award: $685,327.00,
15% effort]
Principal Investigator [1995]: "Clinical assessment of SPECT imaging with Dopascan
injections in patients with Parkinson's disease and healthy controls." Guilford
Pharmaceuticals.[Total: $22,920.00; Indirects: $4,813.20]
Principal Investigator [1992- 1994]: "Double-blind, placebo-controlled, parallel- group
comparison to assess the safety, tolerance, and efficacy of Pramipexole in advanced
Parkinson's disease and to assess long-term safety with open label Pramipexole" Multicenter trial sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. [Total $21,119.90;
Indirects: $4,435.17]
Principal Investigator [1989-1995]: "A triple-blind, randomized study comparing
SINEMET CR (50/200) with SINEMET (25/100) in Parkinson's disease for patients on prior
levodopa therapy." Multicenter trial sponsored by Merck Sharp & Dohme [Total: $
101,901.00; Indirects: $26,494.51]
Publications
Peer Reviewed
1. Reich SG, Weiner SN, Chester S, Ruff RL. Clinical and radiologic features of spontaneous
thigh muscle infarction in the diabetic. Clinical Nuclear Medicine 10:876-879, 1985.
Stephen G. Reich
Page 11 of 39
2. Reich SG. Harvey Cushing's Guillain-Barre Syndrome: an historical diagnosis. Neurosurgery
21(2):135-141, 1987.
3. Reich SG. Destroyers and other verses: Henry Head, the Poet. Archives of Neurology
45(11):1257-1260, 1988.
4. Glass JD, Reich SG, DeLong MR. Wilson's disease: development of neurological disease
after beginning penicillamine therapy. Archives of Neurology 47(5):595-6, 1990.
5. Koller WC, Block GA, Ahlskog JE, Cedarbaum JM, Cyaham G, Goetz C, Lewitt PA, Liss C,
McLean L, Moses H, Reich SG, Singer C, Stellar S, Weiner WJ. Effect of MK-458 (HPMC) in
Parkinson's Disease previously untreated with dopaminergic drugs. Clinical
Neuropharmacology 14(4):322-329, 1991.
6. Ventre J, Zee DS, Papageorgiov H, Reich SG. Predictive saccades in hemiparkinson
disease. Brain 115:1147-1165, 1992.
7. Beck RW, et al. and the Optic Neuritis Study Group (S. Reich). A Randomized, controlled
trial of corticosteroids in the treatment of acute optic neuritis. New England Journal of
Medicine 326(9):581-588,1992.
8. Frost JJ, Rosier AM, Reich SG, Smith JS, Ehlers M, Snyder SH, Ravert HT, Dannals RF.
PET imaging of the dopamine transporter in Parkinson's disease by 11-C-WIN 35,428,
reveals marked declines in mild Parkinson's disease. Annals of Neurology 34:423-431, 1993.
9. Parkinson Study Group (S. Reich). Effects of Tocopherol and Deprenyl on the progression of
disability in early Parkinson’s Disease. The New England Journal of Medicine 328(3): 176183, 1993.
10. Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty D, Brown UT,
Optic Neuritis Study Group (S. Reich). The effect of corticosteroids for acute optic neuritis on
the subsquent development of multiple sclerosis. New England Journal of Medicine 329:17641769, 1993.
11. Repka MX, Claro MC, Loupe DN, Reich SG. Ocular motility in Parkinson's disease. Journal
of Pediatric Ophthalmology and Strabismus 33:144-147;1996.
12. Parkinson Study Group (S. Reich). Impact of deprenyl and tocopherol on Parkinson’s
disease in DATATOP subjects not requiring levodopa. Annals of Neurology 1996;39:29-36.
13. Block G, Liss C, Reines S, Irr J, Nibbelink D, The CR First Study Group (S. Reich).
Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson’s
disease. European Neurology. 37:23-27; 1997
14. Lieberman A, Ranhosky A, Korts D, Pramipexole Study Group (S. Reich). Clinical evaluation
of pramipexole in advanced Parkinson’s disease. Neurology 49:162-168, 1997.
15. Suarez JI, Verhagen, Metman L, Reich SG, Dougherty PM, Hallett M, Lenz FA. Pallidotomy
for hemiballismus: efficacy and characteristics of neuronal activity. Annals of Neurology
42:807-811, 1997.
16. Riviere CN, Reich SG, Thakor NV. Adaptive fourier modeling for quantification of tremor.
Journal of Neuroscience Methods 74;77-87,1997.
Stephen G. Reich
Page 12 of 39
17. Zirh TA, Lenz FA, Reich SG, Dougherty PM. Patterns of bursting occurring in thalamic cells
during Parkinson’s tremor. Neuroscience 83;107-121, 1998.
18. Hua SE, Lenz FA, Zirh TA, Reich SG, Dougherty PM. Thalamic neuronal activity correlated
with essential tremor. Journal of Neurology, Neurosurgery, and Psychiatry 64;273-276,
1998.
19. Persico AM, Reich SG, Henningfield JE, Kuhar MJ, Uhl GR. Parkinsonian patients report
blunted subjective effects of methylphenidate. Experimental and Clinical
Psychopharmacology 6:54-63, 1998.
20. Lenz FA, Suarez JI, Verhagen LM, Reich SG, Chen R, Karp BI, Hallett M, Eckel TS,
Rowland LH, Hua S, Dougherty PM. Pallidal activity during dystonia: somatosensory
reorganization and activity dependent changes in spontaneous activity. Journal of
Neurology, Neurosurgery and Psychiatry 65: 767-770, 1998.
21. Parkinson Study Group (S. Reich). Mortality in DATATOP: a multicenter trial in early
Parkinson’s disease. Annals of Neurology 1998;43:318-325.
22. Ilgin N, Zubieta JK, Reich SG, Dannals RF, Ravert HT, Frost JJ. Dopamine transporter
imaging in Parkinson's disease and progressive supranuclear palsy. Neurology 52:12211226, 1999.
23. Girkin CA, Perry JD, Miller NR, Reich SG. Pachymeningitis with multiple cranial neuropathies and
unilateral optic neuropathy secondary to Pseudomonas aeruginosa: Case Report and Review.
Clinical Neuroophthalmology 18:196-200, 1999.
24. Pharr V, Litvan I, Brad DG, Troncoso J, Reich SG, Stark M. Ideomotor apraxia in progressive
supranuclear palsy: a case study. Movement Disorders 14:162-165, 1999.
25. Zirh A, Reich SG, Dougherty PM, Lenz FA. Stereotactic thalamotomy in the treatment of
essential tremor: re-assessment including a blinded measure of outcome. Journal of
Neurology, Neurosurgery and Psychiatry 66:772-775, 1999.
26. Chambers CB, Lee JM, Tronocoso J, Reich SG, Muma NA. Overexpression of 4 repeat tau
isoforms in progressive supranuclear palsy but not in Alzheimer's disease. Annals of Neurology
46:325-332, 1999.
27. Lenz FA, Jaeger CJ, Seike MS, Lin YC, Reich SG, et al. Thalamic single neuron activity in patients
with dystonia: dystonia-related activity and somatic sensory reorganization. Journal of
Neurophysiology 82:2372-92, 1999
28. Koller WC, Hutton JT, Tolosa E. Carbidopa/levodopa study group (S.Reich). Immediate-release
and controlled-release carbidopa/levodopa in the treatment of Parkinson's disease: a five-year
random mixed, multi-center study. Neurology 53:1012-1019, 1999.
29. Landau WM, Schmidt RE, McGlennen RC, Reich SG. Hereditary spastic paraplegia and
hereditary ataxin part II: a family demonstrating a variety of phenotypic manifestations with SCA 3
genotype. Archives of Neurology 57:733-739, 2000.
30. Parkinson Study Group. (S.Reich). A multi-center asssessment of dopamine transporter imaging
with DOPASCAN/SPECT in parksonism. Neurology 55: 1540 – 1547, 2000.
31. Krauss G, Bergin, A, Reich SG, Yong-Won C. Suppression of Post-Hypoxic Myoclonus with
Levetiracetam, Neurology 56: 411-412, 2001.
Stephen G. Reich
Page 13 of 39
32. Poorkaj P, Grossman M, Steinbart E, Payami H, Sadavnick A, Nochlin D, Tabira T, Trojanowski
JQ, Borson S, Galasko D, Reich SG, Quinn B, Schellenberg G, Bird TD. The Frequency of Tau
Gene Mutations in Familial and Sporadic Cases of non-Alzheimer Dementia. Archives of
Neurology 58:383-387, 2001.
33. Weiner WJ, Factor SA, Jankovic J, Hauser RA, Tetrud JW, Waters CH, Shulman LM, Glassman
PM, Beck B, Paume D, Doyle D, Pramipexole Study Group (S.Reich). The long term safety and
efficacy of pramipexole in advanced parkinson's disease. Parkinsonism and Related Disorders 7:
115-120, 2001.
34. Rajendran PR, Thompson RE, Reich SG. The use of alternative therapies by patients with
Parkinson's disease. Neurology 57:790-794, 2001. (PR Rajendran received the G. Milton Shy
medical student essay award from the American Academy of Neurology).
35. Reich SG. A medical mystery [Neurovignette photograph]. The Neurologist 7: 308, 2001.
36. Marsh L, Reich SG, Lyketsos K. Olanzapine for the treatment of psychosis in patients with
parkinson's disease and dementia. Psychosomatics 42: 477-481, 2002.
37. Lenz FA, Jaeger CJ, Seike MS, Lin YC, Reich SG. Single neuron analysis of human thalamus in
patients with intention tremor and cerebellar signs. Journal of Neurophysiology 87: 2084-2094,
2002.
38. Ramulu P, Moghekar A, Chaudhry V, Zee DS, Reich SG. Wernicke’s encephalopathy
(NeuroImage). Neurology 59:846, 2002.
39. Shults CW, Oakes K, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I,
Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, Kurlan R, Mohlo E, Harrison M,
Lew M, and the Parkinson Study Group. Effects of Coenzyme Q10 in early Parkinson’s diseaseevidence for slowing of the functional decline. Archives of Neurology 59: 1541-1550, 2002.
40. Reider CR, Halter CA, Castellucio PF, Oakes D, Nichols WC, Foroud T, Parkinson Study Group
(S.Reich). Reliability of reported age at onset for Parkinson’s disease. Movement Disorders
2002;18:275-279.
41. Reich SG. The cold hands sign of multisystem atrophy [NeuroImage]. Neurology 2003;60:719.
42. Reich SG, Marsh L. Ten Questions: Psychiatric aspects of Parkinson’s disease. The Neurologist
9:50-56, 2003.
43. Gilstad J, Reich SG. Chorea in an octogenerian. The Neurologist 2003;9:165-166.
44. Foroud T, Uniacke SK, Liu L, Pankratz N, Rudolph A, Halter C, Shults C, Karder K, Conneally PM,
Nichols WC, Parkinson Study Group (S. Reich). Heterozygositiy for a mutation in the parkin gene
leads to later onset Parkinson’s disease. Neurology 2003:60:796-801.
45. Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally PM, Toroud T,
Parkinson Study Group (S. Reich). Significant linkage of Parkinson disease to chromosome 2q3637. American Journal of Human Genetics 2003:72:1053-1057.
46. Optic Neuritis Study Group (S. Reich). High- and low-risk profiles for the development of multiple
sclerosis within 10 year after optic neuritis. Archives of Ophthalmology 2003;121:944-949.
47. Leroi I, Brandt J, Reich SG, Lyketsos K, Grill S, Thompson R, Marsh L. Randomized placebocontrolled trial of donepezil for cognitive impairment in Parkinson’s disease. International Journal
of Geriatric Psychiatry 2004;19:1-8.
Stephen G. Reich
Page 14 of 39
48. Olanow CW, Kieburtz K, Stern M, Watts R, Langston JW, Guarnieri M, Hubble J; US01 Study
Team (SG Reich). Double-blind, placebo-controlled study of entacapone in levodopa-treated
patients with stable Parkinson disease. Arch Neurol 2004;61:1563-1568.
49. Visser JE, Reich SG, Harris JC, Barabas G, Eddey GE, Jinnah HA. The motor disorder of LeschHyhan disease. Nucleosides, Nucleotides, & Nucleic Acids 2004;23:1161-1164.
50. The Parkinson Study Group (Reich SG, Investigator). Levodopa and the progression of
Parkinson’s disease. New England Journal of Medicine 2004;351:2498-2508.
51. Khosla J, Edelman MJ, Kennedy N, Reich SG. West Nile virus presenting as opsoclonusmyoclonus cerebellar ataxia. Neurology 2005;64:1095.
52. Nichols WC, Pankratz N, Hernandez D, Paisan-Ruiz, C, Jain S, Halter CA, Michaels VE, Reed T,
Rudolph A, Shults CW, Singleton A, Forout T, Parkinson Study Group-PROGENI Investigators (S.
Reich). Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
Lancet 2005;365:410-412.
53. Crone NE, Jinnah HA, Reich SG. Wilson disease presenting with an unusual cough. Movement
Disorders 2005;20:891-893.
54. Reich SG, Grill SE. Gustatory sweating: Frey’s syndrome. Neurology 2005;65:E24.
55. Gilman S, May SJ, Shults CW, Tanner CM, Kukull W, Lee VM, Masliah E, Low P, Sandroni P,
Trojanowski JQ, Ozelius L, Foroud T; and The North American Multiple System Atrophy Study
Group (S. Reich) .The North American multiple system atrophy study group. J Neural Transm
2005;112:1687-1694
56. Reich SG. Invited commentary: New and reliable MRI diagnosis for progressive supranuclear
palsy. Nature Clinical Practice Neurology 2006;2:12-13.
57. Blindauer K, Shoulson I, Oakes D, Kieburtz K, Schwid S, Fahn S, Stern M, Goetz C, Nutt J, Goren
S, Sayag N, Scolnik M, Levy R, Eyal E, Salzman P, Pagano M; Parkinson Study Group (Reich
SG). A randomized controlled trial of etilevodopa in patients with Parkinson disease who have
motor fluctuations. Archives of Neurology 2006;63:210-216
58. Schneider SA, Edwards MJ, Grill SE, Goldstein S, Kanchana S, Quinn NP, Bhatia KP, Hallett M,
Reich SG. Adult-onset primary lower limb dystonia. Movement Disorders 2006;2:767-771.
59. Shulman LM, Stevenson R, Anderson KE, Vaughan CG, Gruber-Baldini A, Reich SG, Weiner WJ.
Subjective report vs. objective measurement of activities of daily living in Parkinson’s disease.
Movement Disorders 2006;21:794-799.
60. Jinnah HA, Visser JE, Harris JC, Verdu A, Larovere L, Cebbalos-Picot, Neychev V, Torres R,
Dulac O, Desguerre I, Schretlen DJ, Robey KL, Barabas G, Bloen BR, Nyhan W, de Kremer R,
Eddey GE, Puig J, Reich SG. Delienation of the motor disorder of Lesch-Nyhan disease. Brain
2006;129:1201-1217.
61. Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ. Practice
parameter: diagnosis and prognosis of new onset Parkinson disease. Neurology 2006;66:968975.
62. Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ. Practice
parameter: neuroprotective strategies and alternative therapies for Parkinson disease. Neurology
2006;66:976-982.
Stephen G. Reich
Page 15 of 39
63. Haines S, Chen H, Anderson KE, Fishman PS, Shulman LM, Weiner WJ, Reich SG. When do
patients with Parkinson disease disclose their diagnosis? Neurology 2006;67:488-90.
64. Reich SG. Bell palsy: which side? (Teaching NeuroImage). Neurology 2007;682:E1.
65. Mutations in LRRK2 other than G2019S are rare in a North American-based sample of
familial Parkinson disease. Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA,
Rudolph A, Shults CW, Foroud T, Nichols WC and the Parkinson Study Group-PROGENI
Investigators (S. Reich). Movement Disorders 2006;21: 2257-2260.
66. Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Wojcieszek J, Rudolph A,
Shults CW, Foroud T, Nichols WC and the Parkinson Study Group-PROGENI Investigators
(S. Reich). Mutations in DJ-1 are rare in familial Parkinson disease. Neuroscience Letters
2006;408:209-213.
67. Marek DK, Pauciulo MW, Pankratz N, Halter C, Rudolph A, Shults C, Wojcieszek J, Foroud
T and the Parkinson Study Group-PROGENI investigators (S. Reich). R1514Q substitution in
LRRK2 is not a pathogenic Parkinson disease mutation. Nichols WC, Movement Disorders
2007;22:254-257.
68. Ozelius Laurie J., Foroud T, May S, Senthil G, Sandroni P, Low PA, Reich SG, Colcher A, Stern
MB, Ondo WG, Jankovic J, Huang N, Tanner CM, Novak P, Gilman S, Marshall FJ, Wooten GF,
Chelimsky TC, Shults CW, and the North American Multiple System Atrophy Study Group. The
G2019S mutation in LRRK2 is not associated with multiple system atrophy. Movement Disorders
2007;22:546-549.
69. Boatman DF, Miglioretti DL, Eberwein C. Alidoost M. Reich SG. How accurate are bedside
hearing tests? Neurology 2007;68:1311-1314.
70. Reich SG. It is III alone, or III and IV? (Teaching NeuroImage). Neurology 2007;68:E34.
71. May S, Gilman S, Sowell BB,Thomas RG, Stern MB, Colsher A, Tanner CM, Huang N, Novak P,
Reich SG, Jankovic J, Ondo WG, Low PA, Sandroni P, Lipp A, Marshall FJ, Wooten F, Shults
CW, and the North American Multiple System Atrophy Study Group. Potential Outcome Measures
and Trial Design Issues for Multiple System Atrophy. Mov Disord 2007;22:2371-2377
72. Nichols WC, Elsaesser VE, Pankratz N, Pauciulo MW, Marek DK, Halter CA, Rudolph A, Shults
CW, Foroud T; Parkinson Study Group-PROGENI Investigators (Reich SG, Investigator) . LRRK2
mutation analysis in Parkinson disease families with evidence of linkage to PARK8. Neurology
2007;69:1737-1744.
73. The Parkinson Study Group PRECEPT Investigators (Reich SG, Investigator). Mixed lineage
kinase inhibitor CEP-1347 fails to delay disability in early Parkinson's disease. Neurology
2007;69:1480-1490.
74. Anderson KE, Gruber-Baldine AL, Vaughn CG, Reich SG, Fishman PF, Weiner WJ. The impact
of psychogenic movement disorders on psychiatric co-morbidity, disability, and quality of life
compared to Parkinson’s disease. Movement Disorders 2008;30:790-6.
75. Solomon D, Ramat S, Tomsak RL, Reich SG, Shin R, Zee DS, Leigh RJ. Saccadic Palsy
Following Cardiac Surgery: Characteristics and Pathogenesis. Annals of Neurology 2008;63:35565.
76. Reich SG, Meyer T. Spasmodic dysphonia: adductor and abductor (Teaching NeuroImage).
Neurology 2008;70:e78.
Stephen G. Reich
Page 16 of 39
77. Tanji H, Gruber-Baldini AL, Anderson KE, Pretzer-Aboff I, Reich SG, Fishman PS, Weiner WJ,
Shulman LM. A comparative study of physical performance measures in Parkinson's disease.
Mov Disord (in press).
78. Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Lang AE; Parkinson Study Group
DATATOP Investigators (Reich SG). Predictors of deterioration in health-related quality of life in
Parkinson's disease: results from the DATATOP trial. Mov Disord 2008;23:653-659.
79. Kraker J, Maulucci C, Peng HQ, Reich SG. Pineal metastasis from breast cancer
(Image). Archives of Neurology 2009;66:667.
80. Marras C, Lang AE, Eberly SW, Oakes D, Fahn S, Schwid SR, Hyson C, Shoulson I;
Parkinson Study Group DATATOP and PRECEPT investigators (S. Reich). A comparison of
treatment thresholds in two large Parkinson's disease clinical trial cohorts. Mov Disord
2009;24:2370-2378.
81. Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ.
The clinically important difference on the unified Parkinson's disease rating scale. Arch
Neurol 2010;67:64-70.
82. Jinnah HA, Ceballos-Picot I, Torres RJ, Visser JE, Schretlen DJ, Verdu A, Laróvere LE, Chen
CJ, Cossu A, Wu CH, Sampat R, Chang SJ, de Kremer RD, Nyhan W, Harris JC, Reich SG,
Puig JG; for the Lesch-Nyhan Disease International Study Group. Brain 2010;133:671-89
83. Abhinav K, Marsh L, Crain B, Reich SG, Biglan K. Co-existence of Parkinson's disease and
progressive supranuclear palsy: case report and a review of the literature.. Neurol Sci. 2011
Feb;32(1):159-63.
84. Shaikh AG, Reich S, Zee DS. Pseudonystagmus-clinical features and quantitative
characteristics. Nature Reviews Neurology 2010;6:519-523.
85. Höglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de
Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J,
Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P; PSP Genetics
Study Group, Albin RL, Alonso E, Antonini A, Apfelbacher M, Arnold SE, Avila J, Beach TG,
Beecher S, Berg D, Bird TD, Bogdanovic N, Boon AJ, Bordelon Y, Brice A, Budka H, Canesi
M, Chiu WZ, Cilia R, Colosimo C, De Deyn PP, de Yebenes JG, Kaat LD, Duara R, Durr A,
Engelborghs S, Fabbrini G, Finch NA, Flook R, Frosch MP, Gaig C, Galasko DR, Gasser T,
Gearing M, Geller ET, Ghetti B, Graff-Radford NR, Grossman M, Hall DA, Hazrati LN,
Höllerhage M, Jankovic J, Juncos JL, Karydas A, Kretzschmar HA, Leber I, Lee VM,
Lieberman AP, Lyons KE, Mariani C, Masliah E, Massey LA, McLean CA, Meucci N, Miller BL,
Mollenhauer B, Möller JC, Morris HR, Morris C, O'Sullivan SS, Oertel WH, Ottaviani D,
Padovani A, Pahwa R, Pezzoli G, Pickering-Brown S, Poewe W, Rabano A, Rajput A, Reich
SG, Respondek G, Roeber S, Rohrer JD, Ross OA, Rossor MN, Sacilotto G, Seeley WW,
Seppi K, Silveira-Moriyama L, Spina S, Srulijes K, St George-Hyslop P, Stamelou M,
Standaert DG, Tesei S, Tourtellotte WW, Trenkwalder C, Troakes C, Trojanowski JQ,
Troncoso JC, Van Deerlin VM, Vonsattel JP, Wenning GK, White CL, Winter P, Zarow C,
Zecchinelli AL, Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR,
Hernandez DG, Singleton AB, Farrer MJ, Yu CE, Golbe LI, Revesz T, Hardy J, Lees AJ,
Devlin B, Hakonarson H, Müller U, Schellenberg GD. Identification of common variants
influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 2011;43:699-705.
Stephen G. Reich
Page 17 of 39
86. Robottom BJ, Gruber-Baldini AL, Anderson KE, Reich SG, Fishman PS, Weiner WJ, Shulman
LM. What determines resilience in patients with Parkinson's disease? Parkinsonism Relat
Disord 2012;18:174-177.
87. Robottom B, Reich SG. Exposure to high dosage trihexyphenidyl during pregnancy for
treatment of generalized dystonia: case report and literature review. Neurologist 2011;17:340341.
88. Huang X, Auinger P, Eberly S, Oakes D, Schwarzschild M, Ascherio A, Mailman R, Chen H;
Parkinson Study Group DATATOP Investigators (S. Reich). Serum cholesterol and the
progression of Parkinson's disease: results from DATATOP. PLoS One 2011;6:e22854.
89. Josiah AF, Gruber-Baldini AL, Anderson KE, Fishman PS, Weiner WJ, Reich SG, Shulman
LM. The effects of gait impairment with and without freezing of gait in Parkinson's disease.
Parkinsonism Relat Disord 2012;18:239-242.
90. Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH,
Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER,
Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian
CP, Myers RH, Payami H, Scott WK, Foroud T; PD GWAS Consortium (Reich SG). Metaanalysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol
2012;71:370-384
91. Gold DR, Reich SG. A 55-year-old woman with vertigo: A dizzying conundrum. Neurology
2012;79:e146-52 (Winner of the 2012 Resident and Fellow Writing Award from Neurology)
92. Shulman LM, Katzel LI, Ivey FM, Sorkin JD, Favors K, Anderson KE, Smith BA, Reich SG,
Weiner WJ, Macko RF. Randomized clinical trial of 3 types of physical exercise for patients
with Parkinson disease. Arch Neurol 2012;5:1-8
93. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson
DW,Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE,
Tolosa E, Tröster AI, Vidailhet M, Weiner WJ.Criteria for the diagnosis of corticobasal
degeneration. Neurology 2013;80:496-503.
94. Gold DR, Nadel RE, Vangelakos CG, Davis MJ, Livingston MY, Heath JE, Reich SG, Gojo I,
Morales RE, Weiner WJ. Pearls and Oy-sters: The utility of cytology and flow cytometry in the
diagnosis of leptomeningeal leukemia. Neurology 2013;80:e156-e159.
95. Tanji H, Koyama S, Wada M, Kawanami T, Kurita K, Tamiya G, Saito N, Suzuki K, Kato T,
Anderson KE, Gruber-Baldini AL, Fishman PS, Reich SG, Weiner WJ, Shulman
LM.Comparison of caregiver strain in Parkinson's disease between Yamagata, Japan, and
Maryland, The United States. Parkinsonism Relat Disord 2013
96. Armstrong M, Castellani R, Reich SG. Rapidly " progressive supranuclear palsy, " Movement
Disorders Clinical Practice (in press).
97. The Parkinson Study Group (S. Reich). Coenzyme Q10 in early Parkinson’s disease: No
evidence of benefit. JAMA Neurol 2014;71:543-552.
98. Marek K, Seibyl J, Eberly S, Oakes D, Shoulson I, Lang AE, Hyson C, Jennings D; Parkinson
Study Group PRECEPT Investigators (S. Reich). Longitudinal follow-up of SWEDD subjects
in the PRECEPT Study. Neurology 2014;82:1791-1797.
99. Morrow, C, Smentkowski K, Schwartz S., Armstrong M, Gruber-Baldini A.L, Anderson KE,
Reich SG, Weiner WJ, Shulman LM. Does spouse participation influence quality of life
reporting in patients with Parkinson's disease? Quality of Life Research Parkinsonism Relat
Disord. 2013 Jun;19(6):628-33.
Stephen G. Reich
Page 18 of 39
100. Armstrong MJ, Gruber-Baldini AL, Reich SG, Fishman PS, Lachner C, Shulman LM. Which
features of Parkinson's disease predict earlier exit from the workforce? Parkinsonism Relat
Disord. 2014 Aug 20. pii: S1353-8020
Book and Journal Volumes Edited
1. Reich SG (ed). Zebras. Seminars in Neurology. 16(1) New York:Thieme Medical
Publishers, March, 1996.
2. Reich SG (editor). Movement Disorders. Current Treatment Options in Neurology 6: 175-219,
2004.
3. Reich SG. Movement Disorders (section editor). Current Treatment Options in Neurology
2005;7:203-243.
4. Reich SG (editor). Psychogenic Disorders. Seminars in Neurology 2006(July);26.
5.
Reich SG (editor): Movement Disorders: 100 Instructive Cases. London: Informa, 2008.
6.
Reich SG (editor). Neurologic Pearls. Seminars in Neurology 2010 (February);30.
7. Fahn S, Marder K, Cote L, Reich SG. Frontiers of Science and Clincal Advances in Quality of
Life in Parkinson’s Disease. Movement Disorders (supplement) 2010; 25(3).
Non-Refereed
1. Reich SG. The tired patient - psychologic versus organic causes. Hospital Medicine 1986;22:142154.
2. Wesselmann U, Reich SG. The Dynias. Seminars in Neurology 1996;16:63-74.
3. Buchholz DB, Reich SG. The Managerie of migraine. Seminars in Neurology 16:83-93,1996.
4. Purcell LL, Reich SG. Dysphagia in progressive supranuclear palsy (editorial). Dysphagia
1997:12:144-145.
5. Hua S, Reich SG, Zirh AT, Dougherty PM, Lenz FA. The role of the thalamus and basal ganglia in
parkinsonian tremor: a review of the evidence. Movement Disorders 1998;13 (Supplement 3): 4042, 1998.
6. Reich SG. Psychogenic Tremor: Avoiding a Potentially Slippery Diagnostic Slope (Editorial
comment). Neurology Network Commentary 1999;3:285-289.
7. Kuniyoshi S, Riley D, Zee DS, Reich SG, Whitney C, Leigh RJ. Distinguishing progressive
supranuclear palsy from other forms of Parkinson’s disease: evaluation of new signs. Annals of New
York Academy of Sciences 2002;956:484-486.
8. Kemp LW, Reich SG. Hemifacial spasm. Current Treatment Options in Neurology 2004;6:175-179.
9.
Skidmore F, Reich SG. Tardive dystonia. Current Treatment Options in Neurology 2005;7:231-236.
10.
Stephen G. Reich, MD
Page 19 of 39
Reich, SG. Psychogenic movement disorders. Seminars in Neurology 2006;26:289-296
11.
Weiner WJ, Reich SG. Agonist or levodopa for PD? Ultimately, it doesn’t matter -- neither is good
enough. Neurology 2008;71:470-1.
12.
Reich SG, Grill, SE. Corticobasal Degeneration. Current Treatment Options in Neurology
2009;11:179-85.
13.
Reich SG. Pearls: Hyperkinetic Movement Disorders. Seminars in Neurology 2010;30:15-22.
14.
Weiner WJ, Reich SG. Another trial, another hour (Editorial). Lancet Neurol 2011;10:201-203.
15.
Reich SG, Weiner WJ. Group visits for Parkinson disease: "The doctor will see all of you now".
(Invited editorial) Neurology. 2011;76:1538-9.
Book Chapters
1. Reich SG, DeLong MR. Parkinson's Disease. In Johnson RT (ed). Current Therapy in Neurologic
Disease. Philadelphia:BC Decker, 1990, 247-252. (Reprinted in: Kassirer JP (ed), Current Therapy in
Internal Medicine (3rd Ed). Philadelphia: BC Decker, 1991, 1673-1677).
2. Alexander GE, Reich SG, DeLong MR. Torticollis. In Johnson RT (ed). Current Therapy in Neurologic
Disease. Philadelphia:BC Decker, 1990, 275-278.
3. Reich SG, DeLong MR. Parkinson's Disease. In Johnson RT (ed). Current Therapy in Neurologic
Disease. Philadelphia:BC Decker, 1990, 247-252. (Reprinted in: Kassirer JP (ed), Current Therapy in
Internal Medicine (3rd Ed). Philadelphia: BC Decker, 1991, 1673-1677).
4. Alexander GE, Reich SG, DeLong MR. Torticollis. In Johnson RT (ed). Current Therapy in Neurologic
Disease. Philadelphia:BC Decker, 1990, 275-278.
5. Reich SG, DeLong MR. Common Disorders of Movement: Tremor and Parkinson's Disease. In Barker
LR, Burton JR, Zieve PD (eds). Principles of Ambulatory Medicine (Third ed). Baltimore: Williams and
Wilkens, 1991, 1133-1143.
6. Reich SG. Progressive Supranuclear Palsy. In Johnson RT, Griffin J (eds). Current Therapy in
Neurology.St. Louis, BC Decker, 1993, 250-253.
7. Reich SG. Common disorders of movement: Tremor and Parkinson's disease. In Barker LR, Burton JR,
Zieve PD (eds). Principles of Ambulatory Medicine (Fourth ed.). Baltimore:Williams and Wilkens, 1995,
1217-1229.
8. Reich SG. Movement Disorders. In Stobo JD, Hellmann DB, Ladenson PW, Petty BG, Traill TA (eds).
The Principles and Practice of Medicine. Stamford:Appleton and Lange 1996, 852-856.
9. Reich SG. Dystonia. In Johnson RT, Griffin JW (eds). Current Therapy of Neurologic Disease (Fifth
edition). Philadelphia: Mosby 1996, 286-290.
10. Zirh TA, Reich SG, Perry V, Lenz FA. Thalamic single neuron activity in patients with dystonia. In Fahn
S, Marsden CD, DeLong M. Advances in Neurology, Dystonia 3 Philadelphia: Lippincott-Raven, 1998,
27-32.
19
Stephen G. Reich, MD
Page 20 of 39
11. Reich SG. Common disorders of movement: tremor and Parkinson's disease: In Barker LR, Burton JR,
Zieve PD (eds). Principles of Ambulatory Medicine (Fifth Edition). Baltimore: Williams & Wilkins, 1998,
1274-1285.
12. Reich SG. Approach to the patient with a gait disorder. In Humes HD, et al. Kelley's Textbook of
Internal Medicine (4th edition). Philadelphia: Lippincott Williams & Wilkens, 2000, 2881-2884.
13. Reich SG. Approach to the patient with abnormal movements and tremors. In Humes HD, et al.
Kelley's Textbook of Internal Medicine (4th edition). Philadelphia: Lippincott Williams & Wilkens, 2000,
2884-2888.
14. Reich SG. Parkinson's Disease and related disorders. In Humes HD, et al. Kelley's Textbook of
Internal Medicine (4th edition). Philadelphia: Lippincott Williams & Wilkens, 2000, 2915-2918.
15. Reich SG. Tremor. In: Slavney PR, Hurko O (eds). Common Neurologic and Psychiatric Disorders Seen
and Treated by Primary Care Physicians. Baltimore: Johns Hopkins University Press, 2001, 214-230 .
16. Reich SG, Flint PW, Purcell L,. Dyphagia and Dysarthria. In Johnson RT, Griffin J, McArthur JC:
Current Therapy in Neurolgic Disease. St Louis: Mosby, 2002, 214-230 .
17. Reich SG, Jinnah H. Restless Legs Syndrome. In Katirji B, Kaminski HJ, Preston DC, Ruff RL,
Shapiro BE: Neuromuscular Disorders in Clinical Practice. Boston: Butterworth-Henemann, 2002, 13341341.
18. Reich SG. Parkinson’s Disease. In Albrecht G, Bichenbach J, Mitchell D, Snyder S, Schailak W. The
Encyclopedia of Disability. Sage Press (in press).
19. Weiner WJ, Reich SG, Shulman LM. Parkinson’s disease and other movement disorders. In Dale
Federman DD (eds). American College of Physicians Medicine. WebMD Inc; New York (in press)
DC,
20. Reich SG. Parkinson’s disease. In: Walsh D. Palliative Medicine. Elsevier (in press).
21. Zesiewicz TA, Reich SG. A woman who can walk but not stand”. In: Reich SG (editor): Movement
Disorders: 100 Instructive Cases. London: Informa, 2008, 27-29.
22. Elmer L Ali I, Reich SG. One wrong move leads to another. In: Reich SG (editor): Movement Disorders:
100 Instructive Cases. London: Informa, 2008, 131-133.
23. Reich SG. Is tremor essential? In: Reich SG (editor): Movement Disorders: 100 Instructive Cases.
London: Informa 2008, 373-376.
24. Reich SG, Anderson KE. . Chorea in a septugeniarian. In: Reich SG (editor): Movement Disorders: 100
Instructive Cases. London: Informa 2008, 383-388
25. Reich SG. Ataxia in a son and mother. In: Reich SG (editor): Movement Disorders: 100 Instructive
Cases. London: Informa, 2008: 361-364.
26. Kraakevik J, Reich SG, Nutt J. The case of the freezing man. In: Reich SG (editor): Movement
Disorders: 100 Instructive Cases. London: Informa 2008, 353-356.
27. Reich SG. The Coat Hanger Sign. In: Reich SG (editor): Movement Disorders: 100 Instructive Cases.
London: Informa 2008, 325-328.
28. Sanchez A, Reich SG. A man with a jerky, useless arm. In: Reich SG (editor): Movement Disorders: 100
Instructive Cases. London: Informa 2008, 381-383.
29. Hawley J, Reich SG. Two guitarists with ‘dys-tune-ia’. In: Reich SG (editor): Movement Disorders: 100
Instructive Cases. London: Informa 2008, 409-412.
20
Stephen G. Reich, MD
Page 21 of 39
30. Reich SG. Painful legs moving toes. In: Weiner WJ, Tolosa E. Handbook of Clinical Neurology,
Hyperkinetic Movement Disorders, Vol. 100 (3rd series), Elsevier; 2011;100:375-83
31. Reich SG. The Follow-Up Visit for Parkinson’s Disease. In: Armstrong M, Hawley J, Weiner WJ:
Parkinson’s Disease: A Clinician’s Guide to Management. Oxford , 2014
Abstracts
1. Reich SG. "Harvey Cushing's N.Y.D. (not yet diagnosed) malady." Neurology 36(4)
(Suppl 1):126, 1986.
2. Reich SG, Ruff RL. Yawning man or blepharospasm-oromandibular dystonia? Brueghel's
syndrome revisited. Neurology 36(4) (Suppl 1):211, 1986.
3. Reich SG. Destroyers and other verses: Henry Head the poet. Neurology 37(3) (Suppl 1):263, 1987.
4. Reed RC, Manon-Espaillat R, Osorio I, Reich SG, Salazar, R. Oral activated charcoal
enhances elimination of intravenously administered phenytoin. Clinical Pharmacology and
Therapeutics 41(2): 1987.
5.
Kaminski H, Hlavin ML, Reich SG. Hoover's Signs: The neurologic contributions of Charles Franklin Hoover.
Neurology 38 (Suppl 1):385, 1988.
6. Ventre J, Zee DS, Papageorgiov H, Reich SG. Predictive saccades in hemiparkinson disease.
Society for Neuroscience Abstracts, 1991.
7. Chaudry V, Course A, Reich SG. Sensory conduction block in the ataxic form of
Guillain-Barre Syndrome. American Association for Electrodiagnostic Medicine, 1992.
8. Becker MW, Pardo CA, Brown CF, Reich SG, Crain BJ, Generalized variant of Pick's
Disease with silver negative inclusions. Brain Pathology 4:515, 1994.
9. Ilgin N, Zubieta JK, Reich SG, Ravert TH, Dannals RF. Frost JJ. Differential diagnosis of
Parkinson's disease and progressive supranuclear palsy with PET Imaging of the dopamine
transporter. The Journal of Nuclear Medicine 36:99P, 1995.
10. Ilgin N, Zubieta JK, Reich SG, Ravert TH, Dannals RF, Frost JJ. Preclinical diagnosis of
Parkinson's disease with PET imaging of the dopamine transporter. The Journal of
Nuclear Medicine 36:98P, 1995.
11. Neumann S, Reich SG, Buchholz D, Purcell L, Jones B. Progressive supranuclear palsy:
characteristics of dysphagia in 14 patients. Dysphagia Research Society, 1995.
12. Straumann D, Zee DS, Solomon D, Lewis RF, Reich SG. Violations of Listing's law in
patients with cerebellar atrophy: angular velocity vectors of Upward Drifts are Eye-Fixed. Society
for Neuroscience Abstracts, 1995.
13. Miller NR, Reich SG, Burger PC. Progressive cranial neuropathies in a 60-year old man.
28th Walsh Society Meeting, Salt Lake City, February 10, 1996.
14. Ilgin N, Kruger MJ, Stumpf MJ, Bencherif JB, Zubieta JK, Reich SG, Dannals RF, Frost JJ.
Statistical parametric mapping of dopamine transporter binding in Parkinson's disease by
Society of Nuclear Medicine, 1996.
PET.
15.Lieberman A, Pramipexole Advanced Study Group. Efficacy and safety of pramipexole in advanced
Parkinson's disease patients with "wearing off" phenomena. American Academy ofNeurology,
1996.
16. Neumann S, Buchholz D, Reich SG, Goldberg P, Purcell L, Lenz F, Jones B. Dysphagia
21
Stephen G. Reich, MD
Page 22 of 39
following pallidotomy for Parkinson's disease. Dysphagia 12:110, 1997.
17. Ilgin N, Reich SG, Bencherit B, Goldberg P, Stumpf M, Zubieta JK, Ravert HT, Frost JJ.
Detection of dopamine transporter loss in Parkinson’s disease: a longitudinal study
evaluating the progression of dopaminergic denervation. The Society of Nuclear Medicine, 1997.
18. Averbuch-Heller L, Stahl JS, Reich SG. Lid-eye incoordination in Parkinson’s disease.
Society for Neuroscience, 1997.
19. Jinnah HA, Harris JC, Reich SG, Visser JE, Barabas G, Eddey GE. The motor disorder of Lesch
Nyhan disease. 5th International Congress of Parkinson's Disease and Movement Disorders,
1998.
19. Pulley MT, Chaudhry V, Crawford TO, Reich SG. Autosomal dominant demyelinating hereditary
motor and sensory neuropathy segregating with familial Parkinson's disease in a large kindred.
Neurology 50:A104, 1998.
20. Ilgin N, Bencherif B, Reich SG, Dannals, Ravert HT, Frost JJ. Analysis of dopamine transporter
binding in Parkinson's disease by statistical parametic mapping. European Association of
Nuclear Medicine Congress, Barcelona, Spain. 1999.
21. Rajendran PR, Thompson RE, Reich SG. The use of alternative therapies by patients with
Parkinson's disease. Neurology 54 (suppl 3): A471, 2000.
22. Kuniyoshi SM, Riley DE, Zee DS, Reich SG, Leigh RJ. Evaluation of clinical signs to differentiate
progressive supranuclear palsy from Parkinson’s disease. Neurology 56 (Suppl 3): A458, 2001.
23. Boatman D, Eberwein CA, Miglioretti D, Alidoost M, Reich SG. Evaluation of bedside tests of
hearing. Neurology 56 (Suppl 3): A35, 2001.
24. Kuniyoshi S, Riley D, Zee DS, Reich SG, Whitney C, Leigh RG. Distinguishing progressive
supranuclear palsy from other forms of Parkinson’s disease: evaluation of new signs. Annals of
New York Academy of Sciences 956:484-486, 2002.
25. Reich SG, Lederman MB, Griswold ME. Errors and delays in diagnosing Parkinson’s disease. Ann
Neurol 2002;52:S84.
26. Reich, SG. Steppage gait in Parkinson’s Disease. Movement Disorders 2003;18:1093.
27. Reich SG, O’Hearn E. Low ceruloplasmin in heterozygotes for Wilson’s disease: a copper herring.
Ann Neurol 2003;54:S42.
28. Reich SG, Malecki E, Moliterno AB, Corse AM, Lee LA, Vogelsang GB. Manganese-induced
parkinsonism from total parenteral nutrition: report of a case and review of the literature. Ann
Neurol 2003;54:S73.
29. Reich SG, Grill SE, Goldstein S, Kanchara S, Hallett M. Adult-onset primary foot dystonia.
Neurology 2004;62 (Suppl 5):A514.
30. Shulman LM, Anderson KE, Vaughn CG, Gruber-Baldini A, Fishman PS, Reich SG, Weiner WJ.
Neurology 2004;62 (Suppl 5):A335.
31. Malecki EA, Vaughn CG, Anderson KE, Fishman PS, Reich SG, Weiner WJ, Shulman LM. What
symptoms are most troubling to patients with Parkinson’s disease? Neurology 2004;62 (Suppl
5):A50.
32. Khosla J, Edelman MJ, Kennedy N, Reich SG. West Nile virus presenting as opsoclonusmyoclonus cerebellar ataxia. Ann Neurol 2004;56(suppl 8):S70.
22
Stephen G. Reich, MD
Page 23 of 39
33. Shulman LM, Stevenson R, Anderson KE, Vaughan CG, Gruber-Baldini A, Reich SG, Weiner WJ.
Subjective patient-report versus objective performance-based measurement of activities of daily
living in Parkinson’s disease. Ann Neurol 2004;56(suppl8):S54.
34. Haines S, Chen J, Anderson KE, Fishman PS, Shulman LM, Weiner WJ, Reich SG. Disclosing
the diagnosis of Parkinson’s disease: patient experiences. Movement Disorders 2004;19:1126.
35. Olander EA, Shulman LM, Anderson KE, Reich SG, Vaughan CG, Weiner WJ. Urinary
incontinence in Parkinson’s disease. Movement Disorders 2005;20(Suppl 10):S88.
36. Cornelius J, Reich SG. Diagnostic errors observed in patients referred to a Parkinson’s disease
and movement disorders clinic. Neurology 2005;64(Suppl 1):A75-76.
37. Shulman LM, Gruber-Baldine AL, Anderson KE, Vaughn CG, Fishman PF, Reich SG, Weiner WJ.
The evolution of disability in Parkinson’s disease. Neurology 2005;64(Suppl 1):A395.
38. Anderson KE, Gruber-Baldine AL, Vaughn CG, Reich SG, Fishman PF, Weiner WJ. The impact
of psychogenic movement disorders on psychiatric co-morbidity, disability, and quality of life
compared to Parkinson’s disease. Neurology 2005;64(Suppl 1):A419.
39. Reich SG, Verhagen-Metman L, Karp B, Bara-Jimenez W, Greene P, Eidelberg D, Fahn S,
Breeze RE, Freed CR. Persistent dyskinesias following fetal dopamine neuron implantation for
Parkinson’s disease. A case report with 9-year follow up. American Neurological Association,
September, 2005.
40. Shulman LM, Oh S, Anderson KE, Gruber-Baldini A, Fishman PS, Reich SG, WeinerWJ.
Comparison of Disability and Quality of Life in Chronic Neurological Disorders. American
Neurological Association, September, 2005.
41. Parkinson Study Group (S. Reich, Investigator). A randomized controlled trial of etilevodopa in
Parkinson's disease patients with motor fluctuations. Movement Disorders 2005;20:1237.
42. Reich SG, Shulman LM, Anderson KE, Weiner WJ. Breathholding as a sign of a psychogenic
movement disorder. Neurology 2006;66(Suppl 2):A368.
43. Shulman LM, Anderson KE, Gruber-Baldini AL, Reich SG, Fishman PS, Weiner WJ. Diseasespecific or co-morbid factors- which has the greatest impact on quality of life in Parkinson’s
disease? Neurology 2006;66(Suppl 2):A116.
44. Reich SG, Teubner-Rhodes D. Surprisingly normal handwriting: A sign suggestive of psychogenic
tremor. Movement Disorders 2006;21(Suppl 15):S697.
45. Tanji H, Pretzer-Aboff I, Gruber-Baldini AL, Anderson KE, Reich SG, Fishman PS, Weiner WJ.
Comparison of performance measures for assessment of gait, balance and mobility in patients
with Parkinson's disease. Movement Disorders 2006;21(Suppl. 15):S507.
46. Shulman LM, Anderson KE, Gruber-Baldini AL, Reich SG, Fishman PS, Weiner WJ.
Diseasespecific or co-morbid factors- which has the greatest impact on disability in Parkinson's disease?
Movement Disorders 2006;21(Suppl. 15):S509.
47. Shulman L, Baumgarten M, Gruber-Baldine AL, Anderson KE, Shardell M, Fishman P, Reich SG,
Weiner W. Racial and socioeconomic disparities in patients with parkinsonism. Neurology
2007;68(Suppl 1):A104.
48. Shulman L, Gruber-Baldini AL, Anderson KE, Fishman PF, Reich SG, Weiner WJ. What is a
clinically meaningful difference in the UPDRS? Neurology 2007;68(Suppl 1):A100.
49. Tanner C, Kukull W, Shults C, Comyns K, Bhudkikanok G, May S, Goldman S, Meng C, Gilman
S, Chade A, Kasten M, Colcher A, Huang N, Jankovic J, Low P, Marshall F, Novak P, Ondo W,
23
Stephen G. Reich, MD
Page 24 of 39
Racetter B, Reich S, Sandroni P, Stern M, Wooten GF. Head injury with amnesia and risk of
multiple system atrophy. Neurology 2007;68(Suppl 1):A49.
50. Kane R, Reich S, Short P, Shulman L, Anderson K, Grattan L, Kent J, Weiner W. (July 2006).
Sensitivity of the Automated Neuropsychological Assessment Metrics (ANAM) system for
assessing cognitive changes in Parkinson’s disease. Paper presented at the joint meeting of the
International Neuropsychological Society, German Neuropsychological Society, & Swiss
Neuropsychological Association Conference, Zurich, CH.
51. Anderson KE, Gruber-Baldini AL, Mullins J, Fishman PS, Reich SG, Weiner WJ, Shulman LM.
Does the burden of psychiatric symptoms vary across stages of Parkinson's disease? Movement
Disorders 2007;22(No.12):V.
52. Reich SG, Weiner WJ. Sitting apraxia in progressive supranuclear palsy. Movement Disorders
2007;22(No.12):XI.
53. Anderson KE, Gruber-Baldini A, Mullins RJ, Fishman PF, Reich SG, Weiner WJ. Do psychiatric
symptoms have a a greater impact on quality of life in early or advanced Parkinson's disease?
Ann Neurol 2007;62(suppl 11):S33.
54. Carpenter M, Mullins J, Anderson KE, Fishman PF, Reich SG, Weiner WJ. What motor symptoms
have the greatest effect of patient-reported disabilty in Parkinson's disease? Ann Neurol
2007;62(suppl 11):S34.
55. Shulman LM, Anderson KE, Gruber-Baldini AL, Reich SG, Fishman PS and Weiner WJ, The
impact of gait and mental function on disability in Parkinson’s disease, 2nd International Congress
of gait and Mental Function, Amsterdam, Netherlands, Parkinsonism & Related Disorders
2008:14/Suppl 1:S55.
56. Anderson K, Gordon E, Mullins J, Gruben-Baldine L, Fishman P, Reich S, Shulman L, Weiner W.
How do behavioral symptoms impact on disability and quality of life in Huntington’s disease?
Neurology 2008;70:A436.
57. Robottom BJ, Anderson K, Mullins J, Tai A, Gruber-Baldini A, Fishman P, Reich S, Weiner W,
Shulman L. What determines resilence in patients with Parkinson's disease?
Neurology 2008;70:A287.
58. Mitchell SB, Mullins RJ, Anderson K, Gruber-Baldini A, Hill T, Tanji H, Fishman P, Reich S,
Weiner W, Shulman L. Neurology 2008;70:A58.
59. Shulman L, Gruber-Baldini A, Anderson K, Fishman P, Reich S, Weiner W. What Parkinson's
disease subtypes are associated with greatest disability? Neurology 2008;70:A56.
60. Morris JD, Miller RR, Anderson KE, Fishman PS, Shulman LM, Weiner WJ, Reich SG. The
circumstances associated with falls in Parkinson’s disease. Movement Disorders 2008;23 (Suppl
1):S329.
61. Reich SG. The spectrum of saccadic abnormalities in progressive supranuclear palsy. Movement
Disorders 2008;23 (Suppl 1):S273.
62. Tanji H, Hill TM, Gruber-BaldineAL, Mitchell SB, Anderson KE, Reich SG, Fishman PF, Weiner
WJ, Shulman LM. Detecting early changes of functional status in Parkinson's disease. Movement
Disorders 2008;23 (Suppl 1):S349.
63. Robottom B, Anderson KE, Mullins RJ, Fishman PS, Reich SG, Weiner WJ, Shulman LM. Do
personality traits increase the risk of apathy in Parkinson's disease? Movement Disorders 2008;23
(Suppl 1):S290.
24
Stephen G. Reich, MD
Page 25 of 39
64. Cabassa JC, Sanchez AM, Reich SG.Psychogenic tremor in a 91 year old man. 2nd International
Conference on Psychogenic Movement Disorders, 2009, Washington, DC.
65. Robottom BJ, Anderson KE, Kaplan PW, Reich SG.Co-occurrence of Valsalva and paroxysmal
movement disorder: a red flag suggesting a psychogenic movement disorder. 2nd International
Conference on Psychogenic Movement Disorders, 2009, Washington, DC.
66. Shah RS, McDade EM, Reich SG. Heroin myelopathy: case report and review. Neurology
2009;72(Suppl 3):A85.
67. Medalie JB, Anderson KE, Gruber-Baldini AL, Mullins RM, Mitchell SB, Reich SG, Fishman PS,
Weiner WJ, Shulman LM. Discordance between physician and patient recognition of motor
fluctuations in Parkinson's disease. Movement Disorders 2009;24(Suppl 1):S539.
68. Reich SG, Meyer. Tardive laryngeal dystonia due to metoclopramide. Movement Disorders
2009;24:1878.
69. Robottom BJ, Reich SG. Use of high dose trihexyphenidyl for dystonia during pregnancy.
Movement Disorders 2009;24:1878.
70. Daly FN, Gruber-Baldine AL, Anderson KE, Muir C, Reich SG, Fishman PS, Weiner WJ, Shulman
LS. When is referral for palliative care or hospice appropriate in Parkinson's disease? Movement
Disorders 2009;24:1871.
71. Hawley J, Reich SG. Steppage-like gait in Parkinson's disease. The 3rd International Congress on
Gait and Mental Function, Washington, DC, 2010.
72. Reich SG. Who can walk better backwards than forwards? The 3rd International Congress on Gait
and Mental Function, Washington, DC, 2010.
73. Gruber-Baldini AL, Anderson KE, Weiner WJ, Fishman PS, Reich SG, Shulman LM. The
relationship between gait impairment and self-efficacy in Parkinson's disease. The 3rd
International Congress on Gait and Mental Function, Washington, DC, 2010.
74. Hawley J, Robottom B, Reich SG, Shulman LM, Anderson KE, Fishman PS, Weiner WJ. Is gait
instability and intellectual impairment rare in early corticobasal degeneration? The 3rd International
Congress on Gait and Mental Function, Washington, DC, 2010.
75. Reich SG. Migraine in Dr. Faustus by Thomas Mann. American Academy of Neurology meeting,
Toronto, Canada, March 2010.
76. Shulman L, Gruber-Baldini A, Anderson K, Fishman P, Robottom B, Weiner W, Reich S. Does
baseline sefl-eficacy for managing Parkinson's disease predict outcome? American Academy of
Neurology meeting, Toronto, Canada, March 2010.
78. Iwata NK, Lin PT, Toro C, Mari Z, Hallett M, Reich SG. Hemibody myoclonus associated with
contralateral medullary compression by a dolichoectatic vertebral artery. Movement Disorders
2010;25 (Suppl 2): S491.
79. Gilman S, Low P, May S, Tanner C, Stern M, Sandroni P, Reich S, Marshall F, Novack P,
Jankovic J, Wooten GF, Racette B, Sletten D, Shults C. Prospective 5-year natural history study
of probably multiple system atrophy (MSA) in 175 North American Subjects. Movement Disorders
2010;25 (Suppl 2): S498.
80. Galpern WR, NINDS Pilot Therapeutics Network (NPTUNE) Investigators (S. Reich). Lithium in
progressive supranuclear palsy and corticobasal degeneration. Movement Disorders 2010;25
(Suppl 2): S498.
25
Stephen G. Reich, MD
Page 26 of 39
81. Shulman LM, Gruber-Baldini AL, Anderson KE, Robottom B, Fishman PS, Reich SG, Weiner
WJ. What features of Parkinson disease impact disability and quality of life?
2nd World Parkinson Congress, Glasgow, Scotland, September, 2010. Movement
Disorders,2010; 25(Suppl);S706.
82. Reich SG, Goldman G, Frucht S. Drummer’s dystonia: An unusual form of musician’s dystonia.
Neurology 2011;76 (Suppl 4):A335.
83. Murray EA, Jung BC, Chaffin A, Du AX, Reich S, Margolis R, Ying S. Quality of life is associated
more with depression than with physical disability in patients with cerebellar ataxia. Neurology
2011;76 (Suppl 4):A348.
84. Shulman L, Gruber-Baldini A, Anderson K, Fishman P, Robottom B, Reich S, Weiner W.
Increased reporting of somatic symptoms in Parkinson’s disease. Neurology 2011;76 (Suppl
4):A494.
85. Litvan I, Cunningham CR, Lees P, Jackson J, Juncos J, Riley D, Bordelon Y, Standaert D, Reich
SG, Cambon AC, Jankovic J, Hall DA, Dubinsk R, Shepherd D, Henchcliffe C, Uitti R, Kluger B,
Shprecher D, Marras C, Gallin E, Levernz J, Rai SN. Association of PSP with Chemical
Occupational Exposure Factors. American Neurological Association Meeting, San Diego, CA,
Sept 26, 2011.
86. Beal, M.F. Parkinson Study Group QE3 Investigators. A phase III clinical trial of coenzyme Q10
(QE3) in early Parkinson's disease. Movement Disorders 2012;27 Suppl 1 :346
87. Perry C, Holmes K, Anderson K, Gruber-Baldini A, Fishman P, Shulman L, Weiner W, Reich S.
Are patients with psychogenic movement disorders more likely to be healthcare workers?,
Presented at the American Academy of Neurology 64th Annual Meeting, New Orleans 2012.
88. Shulman L, Gruber-Baldini A, Anderson K, Figari-Jordan R, Fishman P, Reich S, Weiner W, Is
Quality of Life Affected Equally by Decline and Improvement in Parkinson Disease Severity?,
Presented at the American Academy of Neurology 64th Annual Meeting, New Orleans 2012.
89. Morrow C, Smentkowski K, Schwartz S, Gruber-Baldini A, Anderson K, Weiner W, Reich S,
Shulman L, Does Spouse Participation Influence Quality of Life Reporting in Patients with
Parkinson’s Disease?, Presented at the American Academy of Neurology 64th Annual Meeting,
New Orleans 2012.
90. Figari-Jordan R, Gruber-Baldini A, Anderson K, Reich S, Weiner W, Fishman P, Shulman L,
Comparison of Disability and Quality of Life in Parkinsonian Syndromes, Presented at the
American Academy of Neurology 64th Annual Meeting, New Orleans 2012.
91. Figari-Jordan R, Anderson K, Gruber-Baldini A, Reich S, Weiner W, Fishman P, Shulman L,
Comparison of Disability and Quality of Life in Three Different Dementias, Presented at the
American Academy of Neurology 64th Annual Meeting, New Orleans 2012.
92. Figari-Jordan R, Gruber-Baldini A, Anderson K, Armstrong M, Fishman P, Reich S, Weiner W,
Shulman L, Does motor asymmetry predict impairment, disability or quality of life in PD? Mov
Disord 2012;27(4):e13.
93. Holmes K, Chen H, Figari R, Fishman PS, Anderson KE, Shulman LM, Weiner WJ, Reich SG.
Do Patients with Parkinsonism Use Properly Sized Canes? Movement Disorders Society Annual
Meeting, Dublin, Ireland, June, 2012
94. McAllister ML, Gruber-Baldini AL, Anderson KE, Reich SG, Fishman PS, Weiner WJ, Armstrong
M, Shulman LM. "Levodopa Improves Psychiatric Symptoms of Parkinson’s Disease More Than
Dopamine Agonists" Neurology 2013;80(suppl 1):S04.195
26
Stephen G. Reich, MD
Page 27 of 39
95. Akinwale A, Holmes K, Armstrong M, Gruber-Baldini A, Anderson K, Reich S, Fishman P,
Weiner W, Shulman L. Assessing Prevalence and Efficacy of Medication Management Aids in
Patients with Parkinson’s Disease. Neurology 2013;80(suppl 1):P02.086.
96. Holmes K, Morrow C, Gruber-Baldini A, Armstrong M, Reich S, Anderson K, Weiner W, Shulman
L. Multiple Sclerosis Functional Composite vs. UPDRS: Which is the more sensitive measure in
PD? Neurology 2013;80(suppl 1):P04.188.
97. Holmes K, Chen H, Figari R, Fishman P, Anderson K, Shulman L, Weiner W, and Reich S. Do
patients with parkinsonism use properly sized canes? Do patients with parkinsonism use properly
sized canes? Neurology 2013;80(suppl 1):P06.102.
98. Salazar R, Chai T, Fishman P, Eisenberg H, and Reich S. Acute lower urinary tract dysfunction
after bilateral STN deep brain stimulation surgery for PD: Case reports and literature review.
Neurology 2014;81(10 suppl). P.7.051.
99. Martello J, Armstrong A, Gruber-Baldini A, Barr E, Reich S, Fishman P, and Shulman S.
Determinants of the frequency of post-operative DBS office visits. Neurology 2014;81(10 suppl). P
7.052.
100. Armstrong M, Barr E, Gruber-Baldini A, Reich S, Lachner C, Fishman P, and Shulman L.
Association of cognitive screening tests with disability in Parkinson’s Disease. Neurology 2014;81(10
suppl). P5.259.
101. Lachner C, Armstrong M, Gruber-Baldini A, Barr E, Fishman P, Reich S, Weiner W, and
Shulman L. What level of Parkinson’s Disease severity is associated with significant differences in
cognitive function? Neurology 2014;81(10 suppl). P5.258.
102. Reich S, Armstrong M, Sanchez A, and Fried R. Psychogenic movement disorders in
nonagenarians: Report of two cases. Neurology 2014;81(10 suppl). P4.064.
103. Comella C, Perlmutter J, Jinnah H, Adler C, Barbano R, Factor S, Fox S, Goetz C, Galpern W,
Jankovic J, Marsh L, Mcdonald W, Reich S, Rodriguez R, Rosen A, Severt W, Waliczek T, and
Stebbins G. Clinimetric testing of the modules for the Comprehensive Cervical Dystonia Rating Scale
(CCDRS). Neurology 2014;81(10 suppl). S27.004.
104. Armstrong M, Gruber-Baldini A, Reich S, Lachner C, Anderson K, Fishman P, and Shulman L.
What are the determinants of leaving the workforce in Parkinson’s Disease? Neurology 2014;81(10
suppl). S37.005.
Brief Communications
1. Reich SG. Rocky mountain spotless fever (letter). Archives of Internal Medicine 143:181, 1983.
2. Reich SG. Hiccups (letter). JAMA 250:729 (Aug. 12), 1983.
3. Reich SG. It Has Been Said. Perspectives in Biology and Medicine 27(3):384-385, 1984.
4. Reich SG. (letter). Clinical-problem solving: still hazy after all these years. New England Journal of
Medicine 332:333;1995.
5. Krauss GL, Bergin A, Cho YW, Reich SG, Kramer RE. (letter). Suppression of postand post-encephalitic myoclonus with levetiracetam. Neurology 57:1145, 2001.
hypoxic
6. Reich SG. Forward in: Havemann J. A Life Shaken, My Encounter With Parkinson’s Disease.
Baltimore: Johns Hopkins University ix-xi, 2002.
27
Stephen G. Reich, MD
Page 28 of 39
7. Reich SG. Introduction in: Buchholz D. Heal Your Headaches. New York: Workman Publishing
xiii-xiv, 2002
8. Shults C, Haas R, Oakes D, Kieburtz K, Plumb S, Shoulson I, Kurlan R, Beal MF, Juncos J, Watts
R, Nutt J, Carter J, Kompoliti K, Perlmutter J, Reich S, Stern M, Molho E, Harrison M, Lew M
(letter). Coenzyme Q10 in early Parkinson’s disease. Archives of Neurology 2003;60:1172-1173.
9. Reich SG, Weiner WJ (letter). Progression of dystonia in complex regional pain syndrome.
Neurology 2005;64:2162-2163.
10. Reich SG. Review of: Frucht S, Fahn S. Movement Disorder Emergencies. Annals of Neurology
2005;58:816-817.
11. Suchowersky O, Reich SG (letter) re: O. Suchowersky, G. Gronseth, J. Perlmutter, S.
Reich, T. Zesiewicz, and W. J. Weiner. Practice Parameter: Neuroprotective strategies and
alternative therapies for Parkinson disease (an evidence-based review): Report of the Quality
Standards Subcommittee of the American Academy of Neurology (Neurology 2006; 66: 976-982).
Neurology 2006 (Aug 15); Epub.
12. Weiner WJ, Reich SG (letter). Upper limb tremor induced by peripheral nerve injury.
Neurology 2007;69:118.
13. Boatman D, Reich SG (letter). How accurate are bedside hearing tests?
Neurology 2007;69:1382.
14. Reich SG, Boatman-Reich D (letter). Causative factors and epidemiology of bilateral
vestibulopathy in 255 patients. Ann Neurol 2007;62:530
15. Newman-Toker DE, Reich SG (letter). “Wrong way” nystagmus in the AICA syndrome.
Laryngoscope 2008;118:378-9.
The
16. Robottom B, Cabassa J, Wozniak M, Reich SG. Anterior choroidal artery infarct. World Neurology
2008;23.
17. Weiner WJ, Ahlskog E, Factor S, Suchowersky O, Reich S (letter). Initiating therapy in Parkinson's
disease. Ann Neur 2009;65:480-481.
18. Weiner WJ, Reich SG. (letter). Agonist or levodopa for Parkinson’s disease?
doesn’t matter: neither is good enough. Neurology 2009 72: 2137-2138.
Untimately it
19. Reich SG. Neurologic Pearls. (Preface to edited volume). Semin Neurol 2010 ;30(1):3-4.
20. Zaner C, Cabassa J, Pritchard J, Jolly B, Ghandi B, Gabre J, Reich SG. The MRI of
HSV-1 Encephalitis. World Neurology (newsletter of the World Federation of Neurology).
2010;25:12.
21. Reich SG. Quality Improvement in Neurology: AAN Parkinson Disease Quality Measures (letter).
Neurology 2011;77:406.
22. Reich SG. Comment on: B Ritz, PC Lee, CF Lassen, OA Arah. Risk for Parkinson's disease
related to ease of quitting smoking. Neurology 2014;83:1396-1402. In: PracticeUpdate 2014
(http://www.practiceupdate.com/journalscan/13448).
28
Stephen G. Reich, MD
Page 29 of 39
23. Lamichhan D, Reich SG. Comment on: G Respondek, M Stamelou, C Kurz, et al. Variable
phenotypes of progressive supranuclear palsy. Mov Disord 2014;29: 1758-1766. In:
PracticeUpdate 2015 (http://www.practiceupdate.com/journalscan/14899).
Invited Lectures
1. "Endocrinology, Art, and History," Tulane Medical School, Endocrinology Journal Club, New
Orleans, LA, April 22, 1981.
2. "The Doctrine of Signatures," Tulane Medical School History of Medical Society, New Orleans, LA,
May 12, 1983.
3. "Thigh Muscle Infarction in the Diabetic," Neurology Grand Rounds, University Hospitals of
Cleveland, Cleveland, OH, September 20, 1984.
4. "The Medical Art of Edvard Munch," The Handerson Medical History Society, Cleveland, Ohio,
March 12, 1985.
5. "Headaches and Pregnancy," Obstetric Grand Rounds, University Hospitals of Cleveland,
Cleveland, OH, November 22, 1985.
6. "Palatal Myoclonus," Neurology Ground Rounds, University Hospitals of Cleveland, Cleveland,
OH, February 27, 1986.
7. "On Death, Hydrogen Ions, and Chateau Margaux: The H.L. Mencken - George Crile
Connection," The Handerson Medical History Society, Cleveland, OH, March 4, 1986.
8. "Primary Writing Tremor: The 'ins and outs' of 'back and forth'," Neurology Grand Rounds,
University Hospitals of Cleveland, Cleveland, OH, March 5, 1987.
9. "The Diagnosis and Treatment of Tremor," Medical Grand Rounds, Montgomery General
Hospital, Olney, MD, November 5, 1987.
10. "The H.L. Mencken - Harvey Cushing Letters," Culpepper Lecture Series in the History of
Medicine, The Johns Hopkins Hospital, Baltimore, MD, March 1, 1988.
11. "Update on Parkinson's Disease," Topics in Clinical Medicine, The Johns Hopkins Hospital,
Baltimore, MD, May 12, 1989.
12. "Tremor," 17th Annual Geriatrics Symposium, Baltimore, MD, January 25, 1990.
13. "Parkinsonism," Neurology for the Primary Care Practitioner, The Johns Hopkins Hospital,
Baltimore, MD, November 17, 1990.
14. "Essential Tremor," Department of Internal Medicine Grand Rounds, The Johns Hopkins Hospital,
Baltimore, MD, March 2, 1991.
15. "Update on Parkinson's Disease," Department of Internal Medicine Grand Rounds, Franklin
Square Hospital, Baltimore, MD, March 7, 1991.
16. "The Diagnosis and Treatment of Tremor," Department of Psychiatry Grand Rounds, The
University of Maryland School of Medicine, May 2, 1991.
17. "Update on Movement Disorder," Topics in Internal Medicine, The Johns Hopkins Hospital, May 9,
1991.
29
Stephen G. Reich, MD
Page 30 of 39
18. "Torticollis," American Spasmodic Torticollis Association, National Institutes of Health,
Bethesda, MD, May 11, 1991.
19. "An Overview of Progressive Supranuclear Palsy," The Society for Progressive Supranuclear
Palsy, The Johns Hopkins Hospital, May 18, 1991.
20. "The Use of Botulinum Toxin for the Treatment of Movement Disorders," Biennial Meeting of The
Johns Hopkins Medical and Surgical Association Baltimore, MD, June 7, 1991.
21. "Parkinson's Disease," "The Diagnosis and Treatment of Tremor," Hamad Hospital, Doha, Qatar,
June 18 and 20, 1991.
22. "The Effect of Neurological Illness on Handwriting," Association of Forensic Document Examiners,
Boston, MA, October 13, 1991.
23. "Tremor," "Focal Dystonias and the use of Botulinum Toxin," Neurology for the Primary
Practitioner, The Johns Hopkins Medical Institutions, Baltimore, MD, November 9, 1991.
24. "The Diagnosis and Treatment of Tremor," Grand Rounds, Harford Memorial Hospital, Havre de
Grace, MD, November 20, 1991.
25. "New Knowledge for the Management of Parkinson's Disease," Bernadine Z. Paulshock lecture,
Delaware Academy of Family Physicians Sixth Annual Geriatric Medicine Symposium,
Wilmington, DE, December 3, 1991.
26. "Metoclopramide - Induced Movement Disorders," Medical Grand Rounds, Francis Scott Key
Medical Center, Baltimore, MD, December 11, 1991.
27. "Movement Disorders, " Geriatric Symposium (Sponsored by Johns Hopkins Medical Institutions,
The American Geriatric Society and Gerontology Research Center), Baltimore, MD, February 5,
1992.
28. "Parkinson's Disease," Grand Rounds, Maryland General Hospital, Baltimore, MD,
February 11,1992.
29. "Neurology," Recertification Board Review for Physician Assistants (Sponsored by The Maryland
Academy of Physician Assistants and Essex Community College), Baltimore, MD, March 8,
1992.
30. "Differential Diagnosis of Movement Disorders," Imaging of Living Brain Chemistry in Health and
Disease, Johns Hopkins Medical Institutions, Baltimore, MD, March 13, 1992.
31. "Deterioration Following Lumbar Puncture in an Alcoholic Man with Change in Mental Status,"
Department of Internal Medicine Morbidity and Mortality Conference, The Johns Hopkins
Hospital, May 20, 1992.
32. "The ABC's and the DEF's of Parkinson's Disease," presented to the following Parkinson's
Disease Support Groups: Columbia, MD (February 7, 1992), Bel Air, MD (March 13, 1992),
Salisbury, MD (April 27, 1992), Hagerstown, MD (May 6, 1992), York, PA (May 14, 1992),
Severna Park, MD (May 26, 1992), Hershey, PA (June 4, 1992).
33. "Dystonia Syndromes," Colloquia and Workshops on Laryngeal Disorders, The Johns Hopkins
Medical Institutions, Baltimore, MD, September 10, 1992.
34. "The Neurologic Examination Made Ridiculously Simple," Maryland Academy of Physician
Assistants, Baltimore, MD, October 2, 1992.
30
Stephen G. Reich, MD
Page 31 of 39
35. "Beyond James Parkinson: The Varied Symptoms of Parkinson's Disease," Parkinson's Disease
Symposium (for patients), Sponsored by American Parkinson's Disease Center, The Johns
Hopkins Hospital, Baltimore, MD, October 3, 1992.
36. "The Emergence of Cushing's Leadership," History of Neurosurgery Course, Congress of
Neurosurgery, Washington, DC, November 3, 1992.
37. "Overview of Movement Disorders and Drug-Induced Movement Disorders," Professor's Rounds,
Department of Internal Medicine, The Johns Hopkins Hospital, December 2, 1992.
38. "The Neurologic Examination: Back to the Basics," & "Drug-Induced Movement Disorders,"
Neurology for the Primary Practitioner, Baltimore, MD, December 12, 1992.
39. "Differential Diagnosis of Movement Disorders," Brain Imaging in Clinical Practice and Research,
The Johns Hopkins Medical Institutions, Baltimore, MD, March 11, 1993.
40. "Neurology Review," 1993 Recertification Exam Review for Physician Assistants, Essex
Community College, Baltimore, MD, March 14, 1993.
41. "Update on Parkinson's Disease," Department of Internal Medicine Grand Rounds, The Johns
Hopkins Medical Institutions, Baltimore, MD, April 3, 1993.
42. "Transient Global Amnesia," Topics in Internal Medicine, Johns Hopkins Medical Institutions,
Baltimore, MD, May 13, 1993.
43. "Parkinson's Disease," Grand Rounds, Harrisburg Hospital, Harrisburg, PA, May 26, 1993.
44.
"Movement Disorders," Geriatric Fellows Conference, Francis Scott Key Medical Center,
Baltimore, MD, June 14, 1993.
45.
"Parkinson's Disease," The Johns Hopkins Health Plan, Eager Street Clinic, Baltimore, MD,
June 15, 1993.
46.
"Neurological Illness and Handwriting," Association of Forensic Document Examiners,
Cleveland, OH, October 10, 1993.
47.
"Movement Disorders," Interface of Medicine and Psychiatry Course, St. Joseph's
Hospital, Baltimore, MD, November 6, 1993.
48.
"Where is the lesion?: A Review of Clinical Localization," Neurology for the Primary
Care Practitioner, Baltimore, MD, December 11, 1993.
49.
"Neurological Evaluation in Patients with Syncope," Advances in Cardiac Diagnosis and
Treatment (Sponsored by Johns Hopkins Department of Medicine), Baltimore, MD,
January 21, 1994.
50.
"Parkinson's Disease and Movement Disorders," Geriatrics Symposium, (Sponsored by The
American Geriatrics Society and Gerontology Research Center National Institute on Aging),
Baltimore, MD, January 25, 1994.
51.
"Pharmacological Treatment of Spasticity and Dystonia," Spectrum of Developmental
Disabilities XVI (Kennedy Krieger Institute), Baltimore, MD, March 15, 1994.
52.
"Parkinson's Disease," Grand Rounds, Harford Memorial Hospital, Havre de Grace, MD, May
11, 1994.
53.
"Dystonia," Grand Rounds, Department of Rehabilitation Medicine, Sinai Hospital,
Baltimore, MD, June 2, 1994.
31
54.
Stephen G. Reich, MD
Page 32 of 39
"The Neurological Examination - Back to the Basics," Family Medicine Review Course, Eastern
Virginia Medical School, Virginia Beach, VA, June 9, 1994.
55. "Update on Major Neurological Disorders," Maryland Association for Adult Day Care
Conference '94, Baltimore, MD, October 7, 1994.
56.
"An Update on Parkinson's Disease," Medical Grand Rounds, Suburban Hospital, Bethesda,
MD, October 12, 1994.
57.
"Head and Neck Manifestations of Movement Disorder," Second Colloquia and Workshops on
Laryngeal Disorders, The Johns Hopkins Medical Institutions, Department of
Otolaryngology/Head and Neck Surgery, October 24, 1994.
58.
"Movement Disorders," Neurology for the Primary Care Practitioner (Sponsored by Department of
Neurology, Johns Hopkins University School of Medicine), Baltimore, MD, December 3, 1994.
59.
"The Clinical Spectrum of Dystonia," Neurology Grand Rounds, Case Western Reserve
University School of Medicine, Cleveland, OH, February 24, 1995.
60.
"The Clinical Spectrum of Dystonia," Neurology Grand Rounds, Wayne State University School
of Medicine, Detroit, MI, March 31, 1995.
61.
"Gait Disorders in the Elderly," Topics in Internal Medicine, Johns Hopkins Medical
Institutions, Baltimore, MD, May 18, 1995.
62.
"Diagnosis and Treatment of Parkinson's Disease," Maryland Academy of Family Physicians, 47th
Annual Meeting and Scientific Sessions, Ocean City, MD, May 21, 1995.
63.
"An Overview of Movement Disorders," Grand Rounds, Greater Baltimore Medical Center, June
15, 1995.
64.
"Localization in Clinical Neurology," Grand Rounds, Suburban Hospital, Bethesda, MD, June 21,
1995.
65.
"Delirium: How to Think Clearly about Confusion," Neurology for the Primary Care
Practitioner, Baltimore, MD, December 2, 1995.
66.
"The Clinical Spectrum of Dystonia," Neurology Grand Rounds, Johns Hopkins
University School of Medicine, January 11, 1996.
67.
"Update on Movement Disorders," Geriatric Medicine Symposium, Baltimore, MD
January 26, 1996.
68.
"Wilson's disease," Department of Internal Medicine Grand Rounds, Johns Hopkins
University School of Medicine, March 15, 1996.
69.
"Wilson's disease" Topics in Internal Medicine, Johns Hopkins Hospital, May 15, 1996.
70.
"Geriatric Movement Disorders," New Jersey Academy of Family Practitioners, Atlantic
City, NJ, June 27, 1996.
71.
"Medical Therapy for Blepharospasm, Meige Syndrome, and Hemifacial Spasm," and
"Alternative Therapies," Blepharospasm, Meige Syndrome, and Hemifacial Spasm 14th
Annual International Conference and Scientific Symposium, Baltimore, MD, August10, 1996.
72.
"Overview of Movement Disorders," Neurology for the Primary Care Practitioner,
Baltimore, MD, December 17, 1996.
73.
"Update on Parkinson’s Disease," Saturday Medicine, Johns Hopkins Department of
32
Stephen G. Reich, MD
Page 33 of 39
Internal Medicine, January 18, 1997.
74.
"The Clinical Spectrum of Tremor," Neurology Grand Rounds, Johns Hopkins Hospital,
January 30, 1997.
75.
"The Clinical Spectrum of Movement Disorders--New and Old Therapies," Neurosurgery Grand
Rounds, Johns Hopkins, February 26, 1997.
76.
"Movement Disorders," 14th Annual Symposium on Practical Neurology for the Primary Care
Physician, St. Joseph Medical Center, Baltimore, MD, March 22, 1997.
77.
"The Clinical Spectrum of Movement Disorders," Grand Rounds, Union Memorial Hospital,
Baltimore, MD, April 3, 1997.
78.
"Task Specific Movement Disorders," Topics in Internal Medicine, Johns Hopkins, May, 1997.
79.
"The Clinical Spectrum of Movement Disorders," Geriatric Medicine Symposium, Baltimore, MD,
August 22, 1997.
80.
"The Clinical Spectrum of Movement Disorders," American Academy of Otolaryngology, San
Francisco, CA, September 8, 1997.
81.
"Case Studies in Parkinson’s Disease," Kaiser Permanente, Falls Church, VA, October 30,
1997.
82.
"Movement Disorders," Primary Care Geriatrics, Kaiser Permanente, Fairfax Hospital,
Fairfax, VA, November 22, 1997.
83.
"Waiting Room Diagnosis of Movement Disorders, " American College of Physicians,
Maryland Chapter Scientific Meeting, Ellicott City, MD, December 5, 1997.
84.
"Waiting Room Diagnosis of Movement Disorders, " Neurology for the Primary Care Practitioner,
Baltimore, MD, December 6, 1997.
85.
"The Clinical Spectrum of Movement Disorders, " Maryland Speech-Language-Hearing
Association, Baltimore, MD, March 21, 1998.
86.
"Parkinson's Disease, " American Gerintological Association, Baltimore, MD, April 27, 1998.
87.
"The Neurological Examination for Internists, " Topics in Internal Medicine, Johns Hopkins Medical
Institutions, May 7, 1998.
88.
"Where is the Lesion: Case Studies in Neurological Localization, " Saturday Medicine, Johns
Hopkins Medical Institution, Baltimore, MD, May 16, 1998.
89.
"An Update on Parkinson's Disease, " Alzheimer's Disease Research Center, Bayview Medical
Center, June 9, 1998.
90.
"Movement Disorders, " Johns Hopkins Internal Medicine Board Review Course,
Baltimore, MD, August 9, 1998.
91.
"Movement Disorders in Psychiatric Patients," Dominion Hospital, Falls Church, VA,
October 7, 1998.
92.
"Doctor, I Shake," Geriatric Medicine Conference (sponsored by Bayview Medical Center),
Baltimore, MD, October 9, 1998.
33
Stephen G. Reich, MD
Page 34 of 39
93.
"Update on Parkinson’s Disease," Internal Medicine Grand Rounds, Maryland General
Hospital, November 10, 1998.
94.
"Where is the Lesion?" Grand Rounds, Harbor Hospital, Baltimore, MD, January 22, 1999.
95.
"Metoclopramide-Induced Extrapyramidal Side Effects," Medical Grand Rounds, Johns Hopkins,
February 12, 1999.
96.
"The Clinical Spectrum of Dystonia," Neuroscience Conference, Christiana Hosptial, Newark
Delaware, April 29, 1999.
97.
"Ten Pitfalls to Avoid in the Diagnosis of Parkinson’s Disease," Topics in Internal Medicine,
Johns Hopkins, May 6, 1999.
98.
"An Update on Parkinson’s Disease," Family Practice Grand Rounds, York Hospital, York, PA,
July 8, 1999.
99.
"Movement Disorders," Johns Hopkins Internal Medicine Board Review Course, Baltimore,
August 1, 1999.
100. "Pitfalls in the Diagnosis of Parkinson's Disease", Current Topics in Geriatrics, Baltimore,
September 17, 1999.
101. "Overview of Movement Disorders" and "Doctor I Shake", American College of Nurse
Practitioners National Clinical Symposium, Nashville, TN, October 7, 1999.
102. "Pitfalls in the Diagnosis of Parkinson's Disease", Neurology for The Primary Care Practitioner,
Baltimore, December 11, 1999.
103. "The Neurological Examination", Grand Rounds, St. Agnes Hospital, Baltimore, January 20,
2000.
104. "Dysphagia in Movement Disorders", 8th Multidiscipliary Symposium on Dysphagia, Johns
Hopkins, Baltimore, MD., March 23, 2000.
105. "Waiting Room Diagnosis of Movement Disorders", and "10 Pitfalls to Avoid in the Diagnosis of
Parkinson's Disease", 51st Annual Post-Graduate Spring Symposium, Carilion Roanoke
Memorial Hospital, Roanoke, VA., March 24, 2000.
106. "Parkinsonian Syndromes", Neurology Grand Rounds, University of Maryland, Baltimore, MD.,
April 19, 2000.
107. "Ten Pitfalls to Avoid in the Diagnosis of Parkinson's Disease", Grand Rounds, Carlisle Hospital,
Carlisle, PA., May 12, 2000.
108. "The Clinical Spectrum of Dystonia", Neurology Grand Rounds, Georgetown University Medical
Center, Washington, D.C., May 24, 2000.
109. "Movement Disorders" Johns Hopkins Internal Medicine Board Review Course, Baltimore, July
22, 2000.
110. "Tremor: The Ins and Outs of Back and Forth," Current Topics in Geriatrics, Baltimore, MD,
October 12, 2000.
111. "Medical Therapy of Blepharospasm," NINDS and Benign Essential Blepharospasm Research
Foundation Brainstorming Session, Washington, D.C., November 17, 2000.
34
Stephen G. Reich, MD
Page 35 of 39
112. "Parkinson's Disease and Movement Disorders," Topics in Ambulatory Medicine, Baltimore, MD,
December 6, 2000.
113. "Update on the Treatment of Parkinson's Disease," Neurology for the Primary Care Practitioner,
Baltimore, MD, December 9, 2000.
114. "The Clinical Spectrum of Dytonia," Neurology Grand Rounds, University of Mississippi,
Jackson, MS, February 6, 2001.
115. “The Spinocerebellar Ataxias,” Neurology Grand Rounds, Johns Hopkins, March 22, 2001
116. "Pitfalls in the Diagnosis of Parkinson's Disease," Medical Grand Rounds, Greater Baltimore
Medical Center, Towson, MD, March 29, 2001.
117. "Update in the Treatment of Parkinson's Disease," Grand Rounds, Carlisle Hospital, Carlisle,
PA., March 30, 2001.
118. “Funny Faces,” Topics in Internal Medicine, Johns Hopkins, May 11, 2001.
119. “Movement Disorders,” Johns Hopkins Internal Medicine Board Review Course, July 24, 2001.
120. “10 Pitfalls in the Diagnosis of Parkinson’s Disease,” Current Topics in Geriatrics, Johns
Hopkins Geriatric Center, Baltimore, MD, September 20, 2001.
121. “Funny Faces,” Saturday Medicine, Johns Hopkins, October 6, 2001.
122. “The Neurological Examination,” Grand Rounds, Harbor Hospital, Baltimore, MD, November 30,
2001.
123. “Bell’s Palsy,” Johns Hopkins Neurology for the Primary Care Practitioner Course, Baltimore,
MD, December 8, 2001.
124. “Involuntary Movements in the Elderly,” Current Topics in Geriatrics, Sponsored by Johns
Hopkins Geriatrics Center, Baltimore, MD, October 10, 2002.
125. “Bell’s Palsy,” Medical Grand Rounds, Greater Baltimore Medical Center, October 24, 2002.
126. “Classification and Phenomenology of Movement Disorders,” Parkinson’s Disease and
Movement Disorders Update, University of Maryland, Baltimore, MD, November 16, 2003.
127. “10 Pitfalls in the Diagnosis of Parkinson’s Disease,” Grand Rounds, Frederick Memorial
Hospital, Frederick, MD, December 19, 2002.
128. “The Clinical Spectrum of Movement Disorders,” Geriatric Psychiatry Grand Rounds, University
of Maryland School of Medicine, December 22, 2002.
129. “Differential Diagnosis of Parkinson’s Disease and Related Movement Disorders,” Parkinson’s
Disease and Related Movement Disorders in Primary Care Course, Johns Hopkins, Baltimore,
MD, Feb 8, 2003.
130. “Movement Disorders: An Update.” Practical Neurology for the Primary Care Physician, St.
Joseph Hospital, Baltimore, MD, March 22, 2003.
131. “The Clinical Spectrum of Dystonia,” Neurology Grand Rounds, The University of Maryland, April
23, 2003.
132. “Update on Parkinson’s Disease and Movement Disorders,” Town Gown Symposium,
Department of Neurology, The University of Maryland, June 4, 2003.
35
Stephen G. Reich, MD
Page 36 of 39
133. “Clinical Management of Parkinson’s Disease,” Johns Hopkins Bayview Neurology Conference,
June 16, 2003.
134. “Etiology and Pathology of Blepharospasm,” Benign Essential Blepharospasm Research
Foundation annual meeting, Philadelphia, PA, Aug 23, 2003.
135. “Is Parkinson’s Disease Really a Waiting Room Diagnosis?” [Edmund G. Beacham lecture] and
“Tics, Twitches and Tremors: Approach to Patients with Movement Disorders,” Current Topics in
Geriatrics Course (sponsored by Johns Hopkins and The American Geriatrics Society),
Baltimore, MD, Oct 16, 2003.
136. “Parkinsonian Syndromes: Clinical Clues,” and “The Focal Dystonias,” Parkinson’s Disease and
Movement Disorders Update, University of Maryland, Baltimore, Nov 1, 2003.
137. “Update on Movement Disorders,” Annual Town-Gown conference, Department of Neurology,
University of Maryland, Baltimore, June 2, 2004
138. “Classification and Phenomenology of Movement Disorders,” 3rd Annual Update on Movement
Disorders, University of Maryland, Baltimore, MD, November 12, 2004.
139. “Movement Disorders for the Otolaryngologist,” Grand Rounds, Otolaryngology, Johns Hopkins,
Baltimore, MD, March 28, 2005
140. “Movement Disorders for the Otolaryngologist,” Grand Rounds, Otolaryngology, University of
Maryland, April 28, 2005.
141. “Everything the Internist Needs to Know about Parkinson’s disease,” 5th Annual Update in
Internal Medicine, University of Maryland, May 24, 2005.
142. “Update on Movement Disorders,” Annual Town-Gown conference, Department of Neurology,
University of Maryland, Baltimore, MD, June 1, 2005
143. “Parkinson’s disease for the Internist,” Grand Rounds, Greater Baltimore Medical Center,
Baltimore, MD, September 22, 2005
144. “Bell’s Palsy,” Grand Rounds, St. Agnes Medical Center, Baltimore, MD, October 6, 2005
145. “Update on Movement Disorders,” American Academy of Neurology Fall Conference,
Philadelphia, PD, October 30, 2005
146. “The Clinical Spectrum of Gait Disorders,” Neurology Grand Rounds, University of Maryland,
December 14, 2005
147. “Update on Movement Disorders,” American Academy of Neurology Winter Conference, Las
Vegas NV, January 14, 2006
148. “The Clinical Spectrum of Gait Disorders,” Grand Rounds, Union Memorial Hospital,
Baltimore, MD, Feb 16, 2006.
149. “10 Pitfalls in the Diagnosis of Parkinson's disease,” Annual Geriatrics Course, Johns Hopkins,
Baltimore, MD, February 9, 2006
150. “Movement Disorders,” Rehabilitation Medicine Grand Rounds, Sinai Hospital, Baltimore, MD,
February 10, 2006
151. “Disclosing the Diagnosis of Parkinson’s Disease,” World Congress of Parkinson’s Disease,
Washington, DC, February 22, 2006.
36
Stephen G. Reich, MD
Page 37 of 39
152. “Movement Disorders: Some Instructive Cases,” Town Gown Conference, University of
Maryland, Baltimore, MD, June 7, 2006.
153. “Parkinsonian Syndromes,” Videocourse, Movement Disorders Society Annual Meeting,
November 1, 2006, Kyoto, Japan.
154. “Movement Disorders the Internist Need to Know,” Medical Grand Rounds, St. Agnes
Hospital, Baltimore, MD, January 11, 2007.
155. “Psychogenic Movement Disorders,” Neurology Grand Rounds, University of Maryland,
Baltimore, MD, January 17, 2007.
156. “Common Movement Disorders in the Elderly,” Johns Hopkins Current Topics in Geriatrics
Course, Baltimore, MD, February 15, 2007.
157. “Psychogenic Movement Disorders,” Psychiatry Grand Rounds, St. Vincent’s Medical Center,
New York, NY, February 22, 2007.
158. “The Clinical Spectrum of Gait Disorders,” Neurology Grand Rounds, Case Western Reserve,
Cleveland, Ohio, March 23, 2007.
159. “Psychogenic Movement Disorders,” Town-Gown Symposium, University of Maryland, Baltimore,
MD, June 13, 2007.
160. “10 Pitfalls in the Diagnosis of Parkinson’s Disease,” 27th Annual Army Medical Neurology
Conference, Washington, D.C., November 15, 2007.
161. “Tremor: The ins and outs of back and forth,” 35th Annual Current Topics in Geriatrics, Johns
Hopkins, Baltimore, January 17, 2008.
162. “Facial Dyskinesias,” Annual Neurology Town Gown Symposium, University of Maryland School
of Medicine, Baltimore, Maryland, June 11, 2008.
163. “The Clinical Spectrum of Gait Disorders,” Neurology Grand Rounds, Cornell, New York, NY, July
9, 2008.
164. “Facial Dyskinesias,” Neurology Grand Rounds, Stanford, Palo Alto, California,
September 12, 2008.
165. “Clinical Diagnosis of Parkinson’s Disease – Pearls and Pitfalls, De Novo Parkinson’s Disease
Course sponsored by the Movement Disorders Society, San Francisco, CA, September 13,
2008.
166. “The Clinical Spectrum of Dystonia,” Neurology Grand Rounds, George Washington University
School of Medicine, January 6, 2009.
167. “Movement Disorders for Internists,” Internal Medicine Grand Rounds, Greater Baltimore Medical
Center, March 26, 2009.
168. “Facial Dyskinesias,” and “Psychogenic Movement Disorders”, Stephens lecture, University of
Colorado Department of Neurology, Denver, CO, May 13, 2009.
169. “Diagnosis of Parkinson’s Disease: Clinical Features, Motor and Non-Motor,” Movement
Disorders Society annual meeting, Paris, France, June 9, 2009.
170. “Bell’s Palsy,” Grand Round, Frederick Memorial Hospital, Frederick, Maryland, September 10,
2009.
37
Stephen G. Reich, MD
Page 38 of 39
171. “Shakes and Tremors: An Approach to Assessment,” 37th Annual Current Topics in Geriatrics
sponsored by Johns Hopkins, Baltimore, MD, Feb 4, 2010.
172. “Cranial Hyperkinesias,” Neurology Update and Stroke Intensive 2010, University of Miami,
Miami, FL, Feb 19, 2010.
173.“Psychogenic Gait Disorders,” The 3rd International Congress on Gait and Mental
Function, Washington, DC, February 27, 2010.
174. “Bell’s Palsy,” Neurology and Emergency Medicine Grand Rounds, The University of
Maryland School of Medicine, April 28, 2010.
175. “Some Interesting Eye Movements,” 9th Annual Town Gown Neurology Update, The
University of Maryland, June 30, 2010.
176. “Tremor: The ‘ins and outs’ of ‘back and forth’,” Current Clinical Issues in Primary
Care, Pri-Med Conference sponsored by Johns Hopkins and Harvard, Baltimore, MD,
Oct 28, 2010.
177. “Bell’s Palsy,” Family Medicine Grand Rounds, The University of Maryland, December
14, 2010.
178. “Facial Dyskinesias,” Emory University Neurology Grand Rounds, Atlanta, GA,
December 17, 2010.
179. “Bell’s Palsy,” Current Topics in Geriatrics, Johns Hopkins, Baltimore, MD, Feb 10,
2011.
180. “The Spectrum of Saccadic Abnormalities in Progressive Supranuclear Palsy,” A
Tribute to John Leigh Basic and Clinical Ocular Motor and Vestibular Research,
Buenos Aires, Argentina, March 25, 2011.
181. “Psychogenic Gait Disorders,” Cutting Edge Neuroscience for Cutting Edge Clinicians, A
Scientific Symposium Honoring the Career of Dr. Sami Harik, Little Rock, AK, June 4, 2011.
182. “Psychogenic Gait Disorders,” 10th Annual Town-Gown Symposium, Department of Neurology,
The University of Maryland, Baltimore, Maryland, June 22, 2011.
183. “Update on Movement Disorders,” 2011 AAN Fall Meeting, Las Vegas, NV, October 21, 2011.
184. “Waiting Room Diagnosis of Movement Disorders,” Grand Rounds, Greater Baltimore Medical
Center, November 17, 2011.
185. “Parkinson’s Disease: Practical Tips in Evaluating and Managing Your Patient,” Edward G.
Beacham 39th Annual Current Topics in Geriatrics, Baltimore, MD, Feb 16, 2012.
186. “Thigh Muscle Infarction in the Diabetic,” Fronteirs in Neuromuscular Disease and NeuroRehabilitation, Case Western Reserve, Cleveland, OH, October 18, 2012.
187. “I’m so dizzy: Managing the Older Adult with Acute Vertigo,” Edmund G. Beacham 40th Annual
Current Topics in Geriatrics, Johns Hopkins, Baltimore, MD, Feb 15, 2013.
188. “Controveries in Neuroscience Plenary Session” American Academy of Neurology ; “Should
levodopa be Initiated at the Time of Diagnosis,” San Diego, CA, March 21, 2013.
189. “Facial Dyskinesias,” Neurology Grand Rounds, Johns Hopkins, Baltimiore, MD, April 18, 2013
190. “Facial Dyskinesias,” Neurology Grand Rounds, University of Illinois, Peoria, IL, April 26, 2013.
38
Stephen G. Reich, MD
Page 39 of 39
191. Guest speaker, Movement Disorders Video Rounds, The University of Cincinnati, June 5,
2013.
192. “Progressive Supranuclear Palsy: Some Selected Aspects,” University of Maryland William J.
Weiner Town Gown Neurology Update XII, June 26, 2013, Baltimore, MD.
193. Invited speaker, UCSD Movement Disorders Video Rounds, Sept 18,2013, San Diego, CA.
194. “Acute Vertigo” Grand Rounds, Greater Baltimore Medical Center, October 11. 2013,
Baltimore, MD.
195. “Evidence Supporting Early Levodopa Therapy,” 2nd Annual Shaping the Management of
Parkinson’s Disease. Sponsored by Parkinson Study Group and Cleveland Clinic, Feb 8, 2014,
Las Vegas, NV
196. “The Clinical Spectrum of Gait Disorders,” Neurology Grand Rounds, Thomas Jefferson
University, Philadelphia, PA, April 11, 2014.
197. “Psychogenic Gait Disorders,” Human Motor Control: 30 Years of Research at NIH and
Beyond (Program to honor Dr. Mark Hallett), Bethesda, MD, April 24, 2014.
198. “Optimizing Treatment of Parkinson’s Disease: Who’s Afraid of the Big Bad Levodopa?” XIII
William J. Weiner Town & Gown Symposium, Baltimore, MD, June 25, 2014.
39